CE-2012.9.30-10Q


 
 
 
 
 
UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
_______________________________________________________
Form 10-Q
þ
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended September 30, 2012
 
Or
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
(Commission File Number) 001-32410
CELANESE CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Delaware
(State or Other Jurisdiction of
Incorporation or Organization)
98-0420726
(I.R.S. Employer
Identification No.)
 
 
222 W. Las Colinas Blvd., Suite 900N
Irving, TX
(Address of Principal Executive Offices)
75039-5421
(Zip Code)
(972) 443-4000
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ  No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer þ
Accelerated filer o
Non-accelerated filer o (Do not check if a smaller reporting company)
Smaller reporting company o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o  No þ
The number of outstanding shares of the registrant’s Series A common stock, $0.0001 par value, as of October 18, 2012 was 159,532,052.
 
 
 
 
 




CELANESE CORPORATION AND SUBSIDIARIES

Form 10-Q
For the Quarterly Period Ended September 30, 2012

TABLE OF CONTENTS
 
 
Page
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


2




Item 1. Financial Statements 
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2012
 
2011
 
2012
 
2011
 
(In $ millions, except share and per share data)
Net sales
1,609

 
1,807

 
4,917

 
5,149

Cost of sales
(1,285
)
 
(1,406
)
 
(3,992
)
 
(3,987
)
Gross profit
324

 
401

 
925

 
1,162

Selling, general and administrative expenses
(121
)
 
(140
)
 
(379
)
 
(408
)
Amortization of intangible assets
(12
)
 
(17
)
 
(38
)
 
(50
)
Research and development expenses
(24
)
 
(24
)
 
(76
)
 
(72
)
Other (charges) gains, net
2

 
(24
)
 
(1
)
 
(39
)
Foreign exchange gain (loss), net
(4
)
 
1

 
(4
)
 
1

Gain (loss) on disposition of businesses and assets, net
(2
)
 
(1
)
 
(2
)
 
(1
)
Operating profit (loss)
163

 
196

 
425

 
593

Equity in net earnings (loss) of affiliates
50

 
57

 
163

 
146

Interest expense
(44
)
 
(54
)
 
(134
)
 
(166
)
Refinancing expense

 

 

 
(3
)
Interest income

 
1

 
1

 
2

Dividend income - cost investments
1

 
1

 
85

 
80

Other income (expense), net
3

 

 
4

 
9

Earnings (loss) from continuing operations before tax
173

 
201

 
544

 
661

Income tax (provision) benefit
(54
)
 
(34
)
 
(32
)
 
(151
)
Earnings (loss) from continuing operations
119

 
167

 
512

 
510

Earnings (loss) from operation of discontinued operations
(3
)
 

 
(3
)
 
3

Gain (loss) on disposition of discontinued operations

 

 

 

Income tax (provision) benefit from discontinued operations
1

 

 
1

 
(1
)
Earnings (loss) from discontinued operations
(2
)
 

 
(2
)
 
2

Net earnings (loss)
117

 
167

 
510

 
512

Net (earnings) loss attributable to noncontrolling interests

 

 

 

Net earnings (loss) attributable to Celanese Corporation
117

 
167

 
510

 
512

Cumulative preferred stock dividends

 

 

 

Net earnings (loss) available to common stockholders
117

 
167

 
510

 
512

Amounts attributable to Celanese Corporation
 

 
 

 
 

 
 

Earnings (loss) from continuing operations
119

 
167

 
512

 
510

Earnings (loss) from discontinued operations
(2
)
 

 
(2
)
 
2

Net earnings (loss)
117

 
167

 
510

 
512

Earnings (loss) per common share - basic
 

 
 

 
 

 
 

Continuing operations
0.75

 
1.07

 
3.24

 
3.27

Discontinued operations
(0.01
)
 

 
(0.01
)
 
0.01

Net earnings (loss) - basic
0.74

 
1.07

 
3.23

 
3.28

Earnings (loss) per common share - diluted
 

 
 

 
 

 
 

Continuing operations
0.74

 
1.05

 
3.21

 
3.21

Discontinued operations
(0.01
)
 

 
(0.01
)
 
0.01

Net earnings (loss) - diluted
0.73

 
1.05

 
3.20

 
3.22

Weighted average shares - basic
159,123,808

 
156,194,459

 
157,936,063

 
156,147,982

Weighted average shares - diluted
160,094,904

 
159,018,839

 
159,644,166

 
158,965,811


See the accompanying notes to the unaudited interim consolidated financial statements.

3



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME (LOSS)

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2012
 
2011
 
2012
 
2011
 
(In $ millions)
Net earnings (loss)
117

 
167

 
510

 
512

Other comprehensive income (loss), net of tax
 

 
 

 
 

 
 

Unrealized gain (loss) on marketable securities

 

 

 

Foreign currency translation
28

 
(69
)
 
4

 
18

Unrealized gain (loss) on interest rate swaps
(2
)
 
5

 
(1
)
 
14

Pension and postretirement benefits
10

 
4

 
25

 
12

Total other comprehensive income (loss), net of tax
36

 
(60
)
 
28

 
44

Total comprehensive income (loss), net of tax
153

 
107

 
538

 
556

Comprehensive (income) loss attributable to noncontrolling interests

 

 

 

Comprehensive income (loss) attributable to Celanese Corporation
153

 
107

 
538

 
556


See the accompanying notes to the unaudited interim consolidated financial statements.


4



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED CONSOLIDATED BALANCE SHEETS
 
As of
 
As of
 
September 30,
2012
 
December 31,
2011
 
(In $ millions, except share data)
ASSETS
 
 
 
Current Assets
 

 
 

Cash and cash equivalents
928

 
682

Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2012: $9; 2011: $9)
932

 
871

Non-trade receivables, net
188

 
235

Inventories
711

 
712

Deferred income taxes
106

 
104

Marketable securities, at fair value
56

 
64

Other assets
47

 
35

Total current assets
2,968

 
2,703

Investments in affiliates
775

 
824

Property, plant and equipment (net of accumulated depreciation - 2012: $1,454; 2011: $1,316)
3,295

 
3,269

Deferred income taxes
539

 
421

Other assets
446

 
344

Goodwill
768

 
760

Intangible assets, net
174

 
197

Total assets
8,965

 
8,518

LIABILITIES AND EQUITY
 
 
 
Current Liabilities
 

 
 

Short-term borrowings and current installments of long-term debt - third party and affiliates
141

 
144

Trade payables - third party and affiliates
685

 
673

Other liabilities
507

 
539

Deferred income taxes
19

 
17

Income taxes payable
43

 
12

Total current liabilities
1,395

 
1,385

Long-term debt
2,839

 
2,873

Deferred income taxes
131

 
92

Uncertain tax positions
189

 
182

Benefit obligations
1,354

 
1,492

Other liabilities
1,142

 
1,153

Commitments and Contingencies


 


Stockholders’ Equity
 

 
 

Preferred stock, $0.01 par value, 100,000,000 shares authorized (2012 and 2011: 0 issued and outstanding)

 

Series A common stock, $0.0001 par value, 400,000,000 shares authorized (2012: 183,002,903 issued and 159,228,221 outstanding; 2011: 179,385,105 issued and 156,463,811 outstanding)

 

Series B common stock, $0.0001 par value, 100,000,000 shares authorized (2012 and 2011: 0 issued and outstanding)

 

Treasury stock, at cost (2012: 23,774,682 shares; 2011: 22,921,294 shares)
(897
)
 
(860
)
Additional paid-in capital
731

 
627

Retained earnings
2,903

 
2,424

Accumulated other comprehensive income (loss), net
(822
)
 
(850
)
Total Celanese Corporation stockholders’ equity
1,915

 
1,341

Noncontrolling interests

 

Total equity
1,915

 
1,341

Total liabilities and equity
8,965

 
8,518


See the accompanying notes to the unaudited interim consolidated financial statements.

5



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENT OF EQUITY
 
Nine Months Ended
 
September 30, 2012
 
Shares
 
Amount
 
(In $ millions, except share data)
Series A Common Stock
 

 
 

Balance as of the beginning of the period
156,463,811

 

Stock option exercises
3,515,105

 

Purchases of treasury stock
(853,388
)
 

Stock awards
102,693

 

Balance as of the end of the period
159,228,221

 

Treasury Stock
 

 
 

Balance as of the beginning of the period
22,921,294

 
(860
)
Purchases of treasury stock, including related fees
853,388

 
(37
)
Balance as of the end of the period
23,774,682

 
(897
)
Additional Paid-In Capital
 

 
 

Balance as of the beginning of the period
 

 
627

Stock-based compensation, net of tax
 

 
15

Stock option exercises, net of tax
 

 
89

Balance as of the end of the period
 

 
731

Retained Earnings
 

 
 

Balance as of the beginning of the period
 

 
2,424

Net earnings (loss) attributable to Celanese Corporation
 

 
510

Series A common stock dividends
 

 
(31
)
Balance as of the end of the period
 

 
2,903

Accumulated Other Comprehensive Income (Loss), Net
 

 
 

Balance as of the beginning of the period
 

 
(850
)
Other comprehensive income (loss)
 

 
28

Balance as of the end of the period
 

 
(822
)
Total Celanese Corporation stockholders’ equity
 

 
1,915

Noncontrolling Interests
 

 
 

Balance as of the beginning of the period
 

 

Net earnings (loss) attributable to noncontrolling interests
 

 

Balance as of the end of the period
 

 

Total equity
 

 
1,915


See the accompanying notes to the unaudited interim consolidated financial statements.



6



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
 
Nine Months Ended
 
September 30,
 
2012
 
2011
 
(In $ millions)
Operating Activities
 

 
 

Net earnings (loss)
510

 
512

Adjustments to reconcile net earnings (loss) to net cash provided by operating activities
 

 
 

Other charges (gains), net of amounts used
(13
)
 
(8
)
Depreciation, amortization and accretion
236

 
231

Deferred income taxes, net
(96
)
 
7

(Gain) loss on disposition of businesses and assets, net
2

 

Refinancing expense

 
3

Other, net
85

 
49

Operating cash provided by (used in) discontinued operations

 
(9
)
Changes in operating assets and liabilities
 

 
 

Trade receivables - third party and affiliates, net
(62
)
 
(175
)
Inventories
1

 
(167
)
Other assets
15

 
3

Trade payables - third party and affiliates
58

 
77

Other liabilities
(75
)
 
(42
)
Net cash provided by (used in) operating activities
661

 
481

Investing Activities
 

 
 

Capital expenditures on property, plant and equipment
(270
)
 
(241
)
Acquisitions, net of cash acquired
(23
)
 
(8
)
Proceeds from sale of businesses and assets, net
1

 
6

Deferred proceeds from Kelsterbach plant relocation

 
158

Capital expenditures related to Kelsterbach plant relocation
(43
)
 
(174
)
Other, net
(62
)
 
(37
)
Net cash provided by (used in) investing activities
(397
)
 
(296
)
Financing Activities
 

 
 

Short-term borrowings (repayments), net
(7
)
 
(20
)
Proceeds from long-term debt

 
411

Repayments of long-term debt
(32
)
 
(562
)
Refinancing costs

 
(8
)
Purchases of treasury stock, including related fees
(37
)
 
(28
)
Stock option exercises
58

 
19

Series A common stock dividends
(31
)
 
(25
)
Preferred stock dividends

 

Other, net
28

 
(11
)
Net cash provided by (used in) financing activities
(21
)
 
(224
)
Exchange rate effects on cash and cash equivalents
3

 
3

Net increase (decrease) in cash and cash equivalents
246

 
(36
)
Cash and cash equivalents as of beginning of period
682

 
740

Cash and cash equivalents as of end of period
928

 
704


See the accompanying notes to the unaudited interim consolidated financial statements.


7



CELANESE CORPORATION AND SUBSIDIARIES
NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
1. Description of the Company and Basis of Presentation
Description of the Company
Celanese Corporation and its subsidiaries (collectively, the "Company") is a global technology and specialty materials company. The Company’s business involves processing chemical raw materials, such as methanol, carbon monoxide and ethylene, and natural products, including wood pulp, into value-added chemicals, thermoplastic polymers and other chemical-based products.
Definitions
In this Quarterly Report, the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The term "Celanese US" refers to the Company’s subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.
Basis of Presentation
The unaudited interim consolidated financial statements for the three and nine months ended September 30, 2012 and 2011 contained in this Quarterly Report on Form 10-Q ("Quarterly Report") were prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP") for all periods presented. The unaudited interim consolidated financial statements and other financial information included in this Quarterly Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations.
In the opinion of management, the accompanying unaudited consolidated balance sheets and related unaudited interim consolidated statements of operations, comprehensive income (loss), cash flows and equity include all adjustments, consisting only of normal recurring items necessary for their fair presentation in conformity with US GAAP. Certain information and footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission ("SEC"). These unaudited interim consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements as of and for the year ended December 31, 2011, filed on February 10, 2012 with the SEC as part of the Company’s Annual Report on Form 10-K.
Operating results for the three and nine months ended September 30, 2012 are not necessarily indicative of the results to be expected for the entire year.
In the ordinary course of business, the Company enters into contracts and agreements relative to a number of topics, including acquisitions, dispositions, joint ventures, supply agreements, product sales and other arrangements. The Company endeavors to describe those contracts or agreements that are material to its business, results of operations or financial position. The Company may also describe some arrangements that are not material but in which the Company believes investors may have an interest or which may have been included in a Form 8-K filing. Investors should not assume the Company has described all contracts and agreements relative to the Company’s business in this Quarterly Report.
For those consolidated subsidiaries in which the Company's ownership is less than 100%, the outside stockholders' interests are shown as noncontrolling interests.
The Company has reclassified certain prior period amounts to conform to the current period’s presentation.
Estimates and Assumptions
The preparation of unaudited interim consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of revenues, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates.

8



2. Recent Accounting Pronouncements

In July 2012, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2012-02, Testing Indefinite-Lived Intangible Assets for Impairment, an amendment to FASB Accounting Standards Codification ("ASC") Topic 350, Intangibles - Goodwill and Other ("FASB ASC Topic 350"). The update provides an entity with the option first to assess qualitative factors in determining whether it is more likely than not that the indefinite-lived intangible asset is impaired. After assessing the qualitative factors, if an entity determines that it is not more likely than not that the indefinite-lived intangible asset is impaired, then the entity is not required to take further action. If an entity concludes otherwise, then it is required to determine the fair value of the indefinite-lived intangible asset and perform the quantitative impairment test. The ASU is effective for the Company for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. Early adoption was permitted. The Company did not early adopt the provisions of this ASU; however, the Company does not expect the impact of adopting this ASU to be material to the Company's financial position, results of operations or cash flows.
3. Acquisitions, Dispositions, Ventures and Plant Closures
Acquisitions
On January 3, 2012, the Company completed the acquisition of certain assets from Ashland Inc., including two product lines, Vinac® and Flexbond®, to support the strategic growth of the Company's Emulsions business (Note 6). In February 2011, the Company acquired a business primarily consisting of emulsions process technology from Crown Paints Limited. Both of the acquired operations are included in the Industrial Specialties segment. Pro forma financial information since the respective acquisition dates has not been provided as the acquisitions did not have a material impact on the Company’s financial information.
The Company allocated the purchase price of the acquisitions to identifiable intangible assets acquired based on their estimated fair values. The excess of purchase price over the aggregate fair values was recorded as goodwill. Intangible assets were valued using the relief from royalty and discounted cash flow methodologies which are considered Level 3 measurements under FASB ASC Topic 820, Fair Value Measurement ("FASB ASC Topic 820"). The relief from royalty method estimates the Company’s theoretical royalty savings from ownership of the intangible asset. Key assumptions used in this model include discount rates, royalty rates, growth rates, sales projections and terminal value rates, all of which require significant management judgment and, therefore, are susceptible to change. The key assumptions used in the discounted cash flow valuation model include discount rates, growth rates, cash flow projections and terminal value rates. Discount rates, growth rates and cash flow projections are the most sensitive and susceptible to change as they require significant management judgment. The Company, with the assistance of third-party valuation consultants, calculated the fair value of the intangible assets acquired to allocate the purchase price at the respective acquisition date.
Plant Closures
• Spondon, Derby, United Kingdom
In August 2010, the Company announced it would consolidate its global acetate manufacturing capabilities by closing its acetate flake and tow manufacturing operations in Spondon, Derby, United Kingdom. The Company expects to serve its acetate customers under this proposal by optimizing its global production network, which includes facilities in Lanaken, Belgium; Narrows, Virginia; and Ocotlan, Mexico, as well as the Company's acetate affiliate facilities in China. The Company expects the closure of the acetate flake and tow manufacturing operations in Spondon, Derby, United Kingdom to occur during the three months ending December 31, 2012. The Spondon, Derby, United Kingdom operations are included in the Consumer Specialties segment.

• Pardies, France
In July 2009, the Company completed the consultation process with the workers council on its "Project of Closure" and social plan related to the Company’s Pardies, France facility pursuant to which the Company ceased all manufacturing operations and associated activities in December 2009. The Pardies, France operations are included in the Acetyl Intermediates segment.

9



4. Marketable Securities, at Fair Value
The Company’s captive insurance companies and nonqualified trusts hold available-for-sale securities for capitalization and funding requirements, respectively.
The amortized cost, gross unrealized gain, gross unrealized loss and fair values for available-for-sale securities by major security type are as follows:
 
As of
 
As of
 
September 30,
2012
 
December 31,
2011
 
(In $ millions)
Mutual Funds
 
 
 
Amortized cost
56

 
64

Gross unrealized gain

 

Gross unrealized loss

 

Fair value
56

 
64

See Note 16, Fair Value Measurements, for additional information regarding the fair value of the Company's marketable securities.
5. Inventories
 
As of
 
As of
 
September 30,
2012
 
December 31,
2011
 
(In $ millions)
Finished goods
511

 
511

Work-in-process
40

 
38

Raw materials and supplies
160

 
163

Total
711

 
712

6. Goodwill and Intangible Assets, Net
Goodwill
 
Advanced
Engineered
Materials
 
Consumer
Specialties
 
Industrial
Specialties
 
Acetyl
Intermediates
 
Total
 
(In $ millions)
As of December 31, 2011
 

 
 

 
 

 
 

 
 

Goodwill
294

 
246

 
35

 
185

 
760

Accumulated impairment losses

 

 

 

 

Net book value
294

 
246

 
35

 
185

 
760

Acquisitions (Note 3)

 

 
7

 

 
7

Exchange rate changes

 
1

 

 

 
1

As of September 30, 2012
 
 
 
 
 
 
 
 
 
Goodwill
294

 
247

 
42

 
185

 
768

Accumulated impairment losses

 

 

 

 

Net book value
294

 
247

 
42

 
185

 
768

The Company assesses the recoverability of the carrying value of its reporting unit goodwill annually during the third quarter of its fiscal year using June 30 balances or whenever events or changes in circumstances indicate that the carrying amount of the asset may not be fully recoverable. In connection with the Company's annual goodwill impairment test, the Company did not record an impairment loss to goodwill during the nine months ended September 30, 2012.

10



Intangible Assets, Net
Finite-lived intangibles are as follows:
 
Licenses
 
Customer-
Related
Intangible
Assets
 
Developed
Technology
 
Covenants
Not to
Compete
and Other
 
Total
 
 
(In $ millions)
 
Gross Asset Value
 

 
 

 
 

 
 

 
 

 
As of December 31, 2011
32

 
513

 
27

 
22

 
594

 
Acquisitions (Note 3)

 
4

 
3

 
6

 
13

(1) 
Exchange rate changes

 

 

 

 

 
As of September 30, 2012
32

 
517

 
30

 
28

 
607

 
Accumulated Amortization
 
 
 
 
 
 
 
 
 
 
As of December 31, 2011
(13
)
 
(433
)
 
(14
)
 
(18
)
 
(478
)
 
Amortization
(2
)
 
(30
)
 
(2
)
 
(4
)
 
(38
)
 
Exchange rate changes

 

 

 

 

 
As of September 30, 2012
(15
)
 
(463
)
 
(16
)
 
(22
)
 
(516
)
 
Net book value
17

 
54

 
14

 
6

 
91

 
______________________________
(1)  
Weighted average amortization period of intangible assets acquired was 6 years.
Indefinite-lived intangibles are as follows:
 
Trademarks
and Trade Names
 
(In $ millions)
As of December 31, 2011
81

Acquisitions (Note 3)
2

Exchange rate changes

As of September 30, 2012
83

The Company’s trademarks and trade names have an indefinite life. Accordingly, no amortization expense is recorded on these intangible assets. For the nine months ended September 30, 2012, the Company did not renew or extend any intangible assets.
Estimated amortization expense for the succeeding five fiscal years is as follows:
 
(In $ millions)
2013
32

2014
21

2015
10

2016
7

2017
6

The Company assesses the recoverability of the carrying value of its indefinite-lived intangible assets annually during the third quarter of its fiscal year using June 30 balances or whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable. In connection with the Company's annual indefinite-lived intangible assets impairment test, the Company did not record an impairment loss to indefinite-lived intangible assets during the nine months ended September 30, 2012.


11



7. Current Other Liabilities
 
As of
 
As of
 
September 30,
2012
 
December 31,
2011
 
(In $ millions)
Salaries and benefits
85

 
101

Environmental (Note 11)
19

 
25

Restructuring (Note 13)
37

 
44

Insurance
17

 
19

Asset retirement obligations
39

 
22

Derivatives (Note 15)
19

 
26

Current portion of benefit obligations
47

 
47

Interest
41

 
25

Sales and use tax/foreign withholding tax payable
23

 
16

Uncertain tax positions
64

 
70

Other
116

 
144

Total
507

 
539

8. Noncurrent Other Liabilities
 
As of
 
As of
 
September 30,
2012
 
December 31,
2011
 
(In $ millions)
Environmental (Note 11)
83

 
71

Insurance
59

 
64

Deferred revenue
36

 
40

Deferred proceeds(1)
891

 
892

Asset retirement obligations
28

 
42

Derivatives (Note 15)
12

 
13

Income taxes payable
3

 
2

Other
30

 
29

Total
1,142

 
1,153

______________________________
(1) 
Primarily relates to proceeds received from the Frankfurt, Germany Airport as part of a settlement for the Company to cease operations and sell its Kelsterbach, Germany manufacturing site, included in the Advanced Engineered Materials segment (Note 20). Such proceeds will be deferred until the transfer of title to the Frankfurt, Germany Airport.
9. Debt
 
As of
 
As of
 
September 30,
2012
 
December 31,
2011
 
(In $ millions)
Short-Term Borrowings and Current Installments of Long-term Debt - Third Party and Affiliates
 
 
 
Current installments of long-term debt
42

 
38

Short-term borrowings, including amounts due to affiliates
99

 
106

Total
141

 
144

The Company's weighted average interest rate on short-term borrowings, including amounts due to affiliates, was 4.4% as of September 30, 2012 compared to 4.3% as of December 31, 2011.

12



 
As of
 
As of
 
September 30,
2012
 
December 31,
2011
 
(In $ millions)
Long-Term Debt
 
 
 
Senior credit facilities - Term C loan due 2016
1,375

 
1,386

Senior unsecured notes due 2018, interest rate of 6.625%
600

 
600

Senior unsecured notes due 2021, interest rate of 5.875%
400

 
400

Pollution control and industrial revenue bonds, interest rates ranging from 5.7% to 6.7%, due at various dates through 2030
182

 
182

Obligations under capital leases due at various dates through 2054
237

 
248

Other bank obligations, interest rates ranging from 6.2% to 6.3%, due at various dates through 2017
87

 
95

Subtotal
2,881

 
2,911

Current installments of long-term debt
(42
)
 
(38
)
Total
2,839

 
2,873

Senior Notes
In September 2010, Celanese US completed the private placement of $600 million in aggregate principal amount of 6.625% senior unsecured notes due 2018 (the "6.625% Notes") under an indenture dated September 24, 2010 (the "Indenture") among Celanese US, Celanese, the Subsidiary Guarantors and Wells Fargo Bank, National Association, as trustee. In April 2011, Celanese US registered the 6.625% Notes under the Securities Act of 1933, as amended (the "Securities Act"). Celanese US pays interest on the 6.625% Notes on April 15 and October 15 of each year which commenced on April 15, 2011. The 6.625% Notes are redeemable, in whole or in part, at any time on or after October 15, 2014 at the redemption prices specified in the Indenture. Prior to October 15, 2014, Celanese US may redeem some or all of the 6.625% Notes at a redemption price of 100% of the principal amount, plus accrued and unpaid interest, if any, to the redemption date, plus a "make-whole" premium as specified in the Indenture. The 6.625% Notes are senior unsecured obligations of Celanese US and rank equally in right of payment with all other unsubordinated indebtedness of Celanese US. The 6.625% Notes are guaranteed on a senior unsecured basis by Celanese and each of the domestic subsidiaries of Celanese US that guarantee its obligations under its senior secured credit facilities (the "Subsidiary Guarantors").
The Indenture contains covenants, including, but not limited to, restrictions on the Company’s ability to incur indebtedness; grant liens on assets; merge, consolidate, or sell assets; pay dividends or make other restricted payments; engage in transactions with affiliates; or engage in other businesses.
In May 2011, Celanese US completed an offering of $400 million in aggregate principal amount of 5.875% senior unsecured notes due 2021 (the "5.875% Notes") in a public offering registered under the Securities Act. The 5.875% Notes are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors.
The 5.875% Notes were issued under an indenture and a first supplemental indenture, each dated May 6, 2011 (the "First Supplemental Indenture") among Celanese US, Celanese, the Subsidiary Guarantors and Wells Fargo Bank, National Association, as trustee. Celanese US pays interest on the 5.875% Notes on June 15 and December 15 of each year which commenced on December 15, 2011. Prior to June 15, 2021, Celanese US may redeem some or all of the 5.875% Notes at a redemption price of 100% of the principal amount, plus accrued and unpaid interest, if any, to the redemption date, plus a "make-whole" premium as specified in the First Supplemental Indenture. The 5.875% Notes are senior unsecured obligations of Celanese US and rank equally in right of payment with all other unsubordinated indebtedness of Celanese US.
The First Supplemental Indenture contains covenants, including, but not limited to, restrictions on the Company’s ability to incur indebtedness; grant liens on assets; merge, consolidate, or sell assets; pay dividends or make other restricted payments; engage in transactions with affiliates; or engage in other businesses.
Senior Credit Facilities
In September 2010, Celanese US, Celanese, and certain of the domestic subsidiaries of Celanese US entered into an amendment agreement (the "Amendment Agreement") with the lenders under Celanese US’s existing senior secured credit facilities in order to amend and restate the corresponding Credit Agreement, dated as of April 2, 2007 (as previously amended,

13



the "Existing Credit Agreement", and as amended and restated by the Amendment Agreement, the "Amended Credit Agreement"). Our Amended Credit Agreement consists of the Term C loan facility, the Term B loan facility, a $600 million revolving credit facility terminating in 2015 and a $228 million credit-linked revolving facility terminating in 2014.
In May 2011, Celanese US, through its subsidiaries, prepaid its outstanding Term B loan facility under the Amendment Agreement set to mature in 2014 with an aggregate principal amount of $516 million using proceeds from the 5.875% Notes and cash on hand.
The margin for borrowings under the revolving credit facility is currently 2.5% above LIBOR or EURIBOR, as applicable, subject to increase or reduction in certain circumstances based on changes in the Company’s corporate credit ratings. Borrowings under the credit-linked revolving facility and the Term C loan facility bear interest at a variable interest rate based on LIBOR (for US dollars) or EURIBOR (for Euros), plus a margin which varies based on the Company's net leverage ratio.
The estimated net leverage ratio and margin are as follows:
 
As of September 30, 2012
 
Estimated Total Net
Leverage Ratio
 
Estimated
Margin
Credit-linked revolving facility
1.50

 
1.50
%
Term C
1.50

 
2.75
%
The margin on each facility may increase or decrease 0.25% based on the following:
Credit-Linked Revolving Facility
 
Term C Loan Facility
Total Net Leverage Ratio
Margin over LIBOR
or EURIBOR
 
Total Net Leverage Ratio
Margin over LIBOR
or EURIBOR
< = 2.25
1.50%
 
< = 1.75
2.75%
> 2.25
1.75%
 
> 1.75 and < = 2.25
3.00%
 
 
 
> 2.25
3.25%
Term loan borrowings under the Amended Credit Agreement are subject to amortization at 1% of the initial principal amount per annum, payable quarterly. In addition, the Company pays quarterly commitment fees on the unused portions of the revolving credit facility and credit-linked revolving facility of 0.25% and 1.50% per annum, respectively.
The Amended Credit Agreement is guaranteed by Celanese and certain domestic subsidiaries of Celanese US and is secured by a lien on substantially all assets of Celanese US and such guarantors, subject to certain agreed exceptions (including for certain real property and certain shares of foreign subsidiaries), pursuant to the Guarantee and Collateral Agreement, dated as of April 2, 2007.
As a condition to borrowing funds or requesting letters of credit be issued under the revolving facility, the Company’s first lien senior secured leverage ratio (as calculated as of the last day of the most recent fiscal quarter for which financial statements have been delivered under the revolving facility) cannot exceed the threshold as specified below. Further, the Company’s first lien senior secured leverage ratio must be maintained at or below that threshold while any amounts are outstanding under the revolving credit facility.
The Company’s first lien senior secured leverage ratios and the borrowing capacity under the revolving credit facility are as follows:
 
As of September 30, 2012
 
First Lien Senior Secured Leverage Ratio
 
 
 
 
 
 
 
Estimate, if Fully
 
Borrowing
 
Maximum
 
Estimate
 
Drawn
 
Capacity
 
 
 
 
 
 
 
(In $ millions)
Revolving credit facility
3.90
 
1.15
 
1.63
 
600


14



The balances available for borrowing are as follows:
 
As of
 
September 30, 2012
 
(In $ millions)

Revolving Credit Facility
 

Borrowings outstanding

Letters of credit issued

Available for borrowing
600

Credit-Linked Revolving Facility
 
Letters of credit issued
70

Available for borrowing
158

The Amended Credit Agreement contains covenants including, but not limited to, restrictions on the Company’s ability to incur indebtedness; grant liens on assets; merge, consolidate, or sell assets; pay dividends or make other restricted payments; make investments; prepay or modify certain indebtedness; engage in transactions with affiliates; enter into sale-leaseback transactions or hedge transactions; or engage in other businesses.
The Amended Credit Agreement also maintains a number of events of default, including a failure to make any payment of principal or interest when due, a cross default to other debt of Celanese, Celanese US, or their subsidiaries, including the 6.625% Notes and 5.875% Notes, in an aggregate amount equal to more than $40 million and the occurrence of a change of control. Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations under the Amended Credit Agreement.
The Company is in compliance with all of the covenants related to its debt agreements as of September 30, 2012.
10. Benefit Obligations
The components of net periodic benefit costs are as follows:
 
Pension Benefits
 
Postretirement
Benefits
 
Pension Benefits
 
Postretirement Benefits
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2012
 
2011
 
2012
 
2011
 
2012
 
2011
 
2012
 
2011
 
(In $ millions)
 
(In $ millions)
Service cost
7

 
7

 

 

 
21

 
21

 
1

 
1

Interest cost
42

 
45

 
3

 
3

 
127

 
136

 
9

 
9

Expected return on plan assets
(51
)
 
(50
)
 

 

 
(154
)
 
(151
)
 

 

Recognized actuarial (gain) loss
14

 
7

 

 
(1
)
 
43

 
22

 
(1
)
 
(2
)
Prior service credit

 
1

 

 

 
1

 
1

 

 

Curtailment (gain) loss

 

 

 

 

 
(1
)
 

 

Total
12

 
10

 
3

 
2

 
38

 
28

 
9

 
8

Commitments to fund benefit obligations during 2012 are as follows:
 
As of
 
 
 
 
September 30, 2012
 
Expected for 2012
 
 
(In $ millions)
 
Cash contributions to defined benefit pension plans(1)
119

 
144

 
Benefit payments to nonqualified pension plans
17

 
21

 
Benefit payments to other postretirement benefit plans
18

 
25

 
______________________________
(1) 
Includes $15 million of discretionary contributions as of September 30, 2012 and $15 million of expected discretionary contributions.

15



The Company’s estimates of its US defined benefit pension plan contributions reflect the provisions of the Pension Protection Act of 2006.
The Company participates in a multiemployer defined benefit plan in Germany covering certain employees. The Company’s contributions to the multiemployer defined benefit plan are based on specified percentages of employee contributions and totaled $4 million for the nine months ended September 30, 2012.
11. Environmental
General
The Company is subject to environmental laws and regulations worldwide that impose limitations on the discharge of pollutants into the air and water and establish standards for the treatment, storage and disposal of solid and hazardous wastes. The Company believes that it is in substantial compliance with all applicable environmental laws and regulations. The Company is also subject to retained environmental obligations specified in various contractual agreements arising from the divestiture of certain businesses by the Company or one of its predecessor companies.
The components of environmental remediation reserves are as follows:
 
As of
 
As of
 
September 30,
2012
 
December 31,
2011
 
(In $ millions)
Demerger obligations (Note 17)
34

 
34

Divestiture obligations (Note 17)
22

 
24

Active sites
28

 
20

US Superfund sites
15

 
14

Other environmental remediation reserves
3

 
4

Total
102

 
96

Remediation
Due to its industrial history and through retained contractual and legal obligations, the Company has the obligation to remediate specific areas on its own sites as well as on divested, orphan or US Superfund sites (as defined below). In addition, as part of the demerger agreement between the Company and Hoechst AG ("Hoechst"), a specified portion of the responsibility for environmental liabilities from a number of Hoechst divestitures was transferred to the Company (Note 17). The Company provides for such obligations when the event of loss is probable and reasonably estimable. The Company believes that environmental remediation costs will not have a material adverse effect on the financial position of the Company, but may have a material adverse effect on the results of operations or cash flows in any given period.
US Superfund Sites
In the US, the Company may be subject to substantial claims brought by US federal or state regulatory agencies or private individuals pursuant to statutory authority or common law. In particular, the Company has a potential liability under the US Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and related state laws (collectively referred to as "Superfund") for investigation and cleanup costs at certain sites. At most of these sites, numerous companies, including the Company, or one of its predecessor companies, have been notified that the Environmental Protection Agency, state governing bodies or private individuals consider such companies to be potentially responsible parties ("PRP") under Superfund or related laws. The proceedings relating to these sites are in various stages. The cleanup process has not been completed at most sites and the status of the insurance coverage for some of these proceedings is uncertain. Consequently, the Company cannot accurately determine its ultimate liability for investigation or cleanup costs at these sites.
As events progress at each site for which it has been named a PRP, the Company accrues, as appropriate, a liability for site cleanup. Such liabilities include all costs that are probable and can be reasonably estimated. In establishing these liabilities, the Company considers its shipment of waste to a site, its percentage of total waste shipped to the site, the types of wastes involved, the conclusions of any studies, the magnitude of any remedial actions that may be necessary and the number and viability of other PRPs. Often the Company joins with other PRPs to sign joint defense agreements that settle, among PRPs, each party’s percentage allocation of costs at the site. Although the ultimate liability may differ from the estimate, the Company routinely reviews the liabilities and revises the estimate, as appropriate, based on the most current information available.

16



One such site is the Lower Passaic River Study Area. The Company and 70 other companies are parties to a May 2007 Administrative Order on Consent with the US Environmental Protection Agency ("EPA") to perform a Remedial Investigation/Feasibility Study ("RI/FS") of the contaminants in the lower 17-mile stretch known as the Lower Passaic River Study Area. The RI/FS is ongoing and may take several more years to complete. The Company is among a group of settling parties to a June 2012 Administrative Order on Consent with the EPA to perform a removal action within a small section of the river. The Company has also been named as a third-party defendant along with more than 200 other entities in an action initially brought by the New Jersey Department of Environmental Protection ("NJDEP") in the Supreme Court of New Jersey against Occidental Chemical Corporation and several other companies. This suit by the NJDEP seeks recovery of past and future clean-up costs, as well as unspecified economic damages, punitive damages, penalties and a variety of other forms of relief arising from alleged discharges into the Lower Passaic River. 
In 2007, the EPA issued a draft study that evaluated alternatives for early remedial action of a portion of the Passaic River at an estimated cost of $900 million to $2.3 billion. Several parties commented on the draft study, and to date, the EPA has not taken further action. The contamination allegedly released by the Company is likely an insignificant aspect of the final remedy, which would consequently limit the ultimate contribution from the Company. Because the RI/FS is still ongoing, and the EPA has not finalized its study or the scope of requested cleanup, and the Company's assessment that the contamination allegedly released by the Company is likely an insignificant aspect of the final remedy, the Company cannot reliably estimate its portion of the final remedial costs for this matter at this time. However, the Company currently believes that its portion of the costs would be less than approximately 1% to 2%. The Company is vigorously defending these and all related matters.
12. Stockholders’ Equity
Common Stock
The Company’s Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of the Company’s Series A Common Stock, par value $0.0001 per share ("Common Stock") unless the Company’s Board of Directors, in its sole discretion, determines otherwise. The amount available to pay cash dividends is restricted by the Company’s Amended Credit Agreement, the 6.625% Notes and the 5.875% Notes.
On April 23, 2012, the Company announced that its Board of Directors approved a 25% increase in the Company's quarterly Common Stock cash dividend. The Board of Directors increased the quarterly dividend rate from $0.06 to $0.075 per share of Common Stock on a quarterly basis and $0.24 to $0.30 per share of Common Stock on an annual basis beginning in August 2012.
Treasury Stock
The Company’s Board of Directors authorized the repurchase of Common Stock as follows:
 
Authorized Amount
 
(In $ millions)
February 2008
400

October 2008
100

April 2011
129

As of September 30, 2012
629

The authorization gives management discretion in determining the timing and conditions under which shares may be repurchased. The share repurchase activity pursuant to this authorization is as follows:
 
Nine Months Ended
 
Total From
February 2008 Through
 
September 30,
 
 
2012
 
2011
 
September 30, 2012
Shares repurchased
853,388

 
591,356

 
12,936,196

Average purchase price per share
$
43.19

 
$
47.37

 
$
38.12

Amount spent on repurchased shares (in millions)
$
37

 
$
28

 
$
493

The purchase of treasury stock reduces the number of shares outstanding and the repurchased shares may be used by the Company for compensation programs utilizing the Company’s stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of stockholders’ equity.

17



Other Comprehensive Income (Loss), Net
 
Three Months Ended September 30,
 
2012
 
2011
 
Gross
Amount
 
Income
Tax
(Provision)
Benefit
 
Net
Amount
 
Gross
Amount
 
Income
Tax
(Provision)
Benefit
 
Net
Amount
 
(In $ millions)
Unrealized gain (loss) on marketable securities

 

 

 

 

 

Foreign currency translation
28

 

 
28

 
(69
)
 

 
(69
)
Unrealized gain (loss) on interest rate swaps
(2
)
 

 
(2
)
 
7

 
(2
)
 
5

Pension and postretirement benefits
15

 
(5
)
 
10

 
6

 
(2
)
 
4

Total
41

 
(5
)
 
36

 
(56
)
 
(4
)
 
(60
)
 
Nine Months Ended September 30,
 
2012
 
2011
 
Gross
Amount
 
Income
Tax
(Provision)
Benefit
 
Net
Amount
 
Gross
Amount
 
Income
Tax
(Provision)
Benefit
 
Net
Amount
 
(In $ millions)
Unrealized gain (loss) on marketable securities

 

 

 

 

 

Foreign currency translation
4

 

 
4

 
18

 

 
18

Unrealized gain (loss) on interest rate swaps
(1
)
 

 
(1
)
 
22

 
(8
)
 
14

Pension and postretirement benefits
41

 
(16
)
 
25

 
19

 
(7
)
 
12

Total
44

 
(16
)
 
28

 
59

 
(15
)
 
44

Adjustments to Accumulated other comprehensive income (loss) are as follows:
 
 
 
Unrealized
Gain (Loss) on
Marketable
Securities
 
Foreign
Currency
Translation
 
Unrealized
Gain (Loss)
on Interest
Rate Swaps
 
Pension and
Postretire-
ment
Benefits
 
Accumulated
Other
Comprehensive
Income
(Loss), Net
 
 
 
(In $ millions)
As of December 31, 2011
(1
)
 
(28
)
 
(57
)
 
(764
)
 
(850
)
Current period change

 
4

 
(1
)
 
41

 
44

Income tax (provision) benefit

 

 

 
(16
)
 
(16
)
As of September 30, 2012
(1
)
 
(24
)
 
(58
)
 
(739
)
 
(822
)
13. Other (Charges) Gains, Net
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2012
 
2011
 
2012
 
2011
 
(In $ millions)
Employee termination benefits
(1
)
 
(5
)
 
(2
)
 
(18
)
Kelsterbach plant relocation (Note 20)
(3
)
 
(14
)
 
(5
)
 
(43
)
Plumbing actions (Note 17)
4

 
2

 
4

 
6

Commercial disputes
2

 
(7
)
 
2

 
15

Other

 

 

 
1

Total
2

 
(24
)
 
(1
)
 
(39
)
2012
No significant Other (charges) gains, net were incurred during the nine months ended September 30, 2012.

18



2011
As a result of the Company's Pardies, France Project of Closure and the planned closure of the Company's Spondon, Derby, United Kingdom facility (Note 3), the Company recorded $4 million and $3 million, respectively, of employee termination benefits during the nine months ended September 30, 2011. Additionally, the Company recorded $5 million of employee termination benefits during the nine months ended September 30, 2011 related to the relocation of the Company's polyacetal ("POM") operations located in Kelsterbach, Germany (Note 20).
During the nine months ended September 30, 2011, the Company received consideration of $17 million in connection with the settlement of a claim against a bankrupt supplier (Note 17). In addition, the Company also recovered an additional $4 million from the settlement of an unrelated commercial dispute. These commercial dispute resolutions are included in the Acetyl Intermediates segment.
The changes in the restructuring reserves by business segment are as follows:
 
Advanced
Engineered
Materials
 
Consumer
Specialties
 
Industrial
Specialties
 
Acetyl
Intermediates
 
Other
 
Total
 
(In $ millions)
Employee Termination Benefits
 

 
 

 
 

 
 

 
 

 
 

As of December 31, 2011
8

 
18

 

 
5

 
11

 
42

Additions

 
4

 

 

 

 
4

Cash payments
(2
)
 
(1
)
 

 
(3
)
 
(3
)
 
(9
)
Other changes

 

 

 

 
(2
)
 
(2
)
Exchange rate changes

 
1

 

 

 

 
1

As of September 30, 2012
6

 
22

 

 
2

 
6

 
36

Plant/Office Closures
 

 
 

 
 

 
 

 
 

 
 

As of December 31, 2011

 

 

 
1

 
1

 
2

Additions

 

 

 

 

 

Cash payments

 

 

 

 

 

Other changes

 

 

 

 
(1
)
 
(1
)
Exchange rate changes

 

 

 

 

 

As of September 30, 2012

 

 

 
1

 

 
1

Total
6

 
22

 

 
3

 
6

 
37

14. Income Taxes
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2012
 
2011
 
2012
 
2011
Effective income tax rate
31
%
 
17
%
 
6
%
 
23
%
For the three months ended September 30, 2012, the higher effective tax rate is primarily due to changes in uncertain tax positions and increases in losses in jurisdictions not providing tax benefits. The lower effective rate for the nine months ended September 30, 2012 is primarily due to foreign tax credit carryforwards partially offset by deferred tax charges related to changes in assessment regarding permanent reinvestment of certain foreign earnings.
During the three months ended March 31, 2012, the Company determined that it was beneficial to amend certain prior year income tax returns to recognize the benefit of available foreign tax credit carryforwards. As a result, the Company recognized a tax benefit of $142 million. The available foreign tax credits are subject to a ten year carryforward period and expire beginning 2014 through 2021. The Company expects to fully utilize the credits within the prescribed carryforward period.
On February 15, 2012, the Company amended its existing joint venture and other related agreements with its venture partner in Polyplastics Co., Ltd ("Polyplastics"). The amended agreements ("Agreements"), among other items, modified certain dividend rights, resulting in a cash dividend payment to the Company of $72 million during the three months ended March 31, 2012. In addition, as a result of the Agreements, Polyplastics is required to pay certain annual dividends to the venture partners. 

19



Consequently, Polyplastics' undistributed earnings will no longer be invested indefinitely. Accordingly, the Company recognized a deferred tax liability of $38 million that was recorded to Income tax provision (benefit) in the unaudited interim consolidated statement of operations during the three months ended March 31, 2012, related to the taxable outside basis difference of its investment in Polyplastics.
The Company's US tax returns for the years 2009 and 2010 are currently under audit by the US Internal Revenue Service and certain of the Company's subsidiaries are under audit in jurisdictions outside of the US. In addition, certain statutes of limitations are scheduled to expire in the near future. It is reasonably possible that a further change in the unrecognized tax benefits may occur within the next twelve months related to the settlement of any of these audits or the lapse of applicable statutes of limitations. Such amounts have been reflected as the current portion of uncertain tax positions (Note 7).
15. Derivative Financial Instruments
Interest Rate Risk Management
To reduce the interest rate risk inherent in the Company’s variable rate debt, the Company utilizes interest rate swap agreements to convert a portion of its variable rate borrowings into a fixed rate obligation. These interest rate swap agreements are designated as cash flow hedges and fix the LIBOR portion of the Company’s US-dollar denominated variable rate borrowings (Note 9). If an interest rate swap agreement is terminated prior to its maturity, the amount previously recorded in Accumulated other comprehensive income (loss), net is recognized into earnings over the period that the hedged transaction impacts earnings. If the hedging relationship is discontinued because it is probable that the forecasted transaction will not occur according to the original strategy, any related amounts previously recorded in Accumulated other comprehensive income (loss), net are recognized into earnings immediately.
US-dollar interest rate swap derivative arrangements are as follows:
As of September 30, 2012
Notional Value
 
Effective Date
 
Expiration Date
 
Fixed Rate (1)
(In $ millions)
 
 
 
 
 
 
1,100

 
January 2, 2012
 
January 2, 2014
 
1.71
%
500

 
January 2, 2014
 
January 2, 2016
 
1.02
%
______________________________
(1) 
Fixes the LIBOR portion of the Company's US-dollar denominated variable rate borrowings (Note 9).
As of December 31, 2011
Notional Value
 
Effective Date
 
Expiration Date
 
Fixed Rate (1)
(In $ millions)
 
 
 
 
 
 
800

 
April 2, 2007
 
January 2, 2012
 
4.92
%
400

 
January 2, 2008
 
January 2, 2012
 
4.33
%
200

 
April 2, 2009
 
January 2, 2012
 
1.92
%
1,100

 
January 2, 2012
 
January 2, 2014
 
1.71
%
______________________________
(1) 
Fixes the LIBOR portion of the Company's US-dollar denominated variable rate borrowings (Note 9).
Foreign Exchange Risk Management
Certain subsidiaries have assets and liabilities denominated in currencies other than their respective functional currencies, which creates foreign exchange risk. The Company also enters into foreign currency forwards and swaps to minimize its exposure to foreign currency fluctuations. Through these instruments, the Company mitigates its foreign currency exposure on transactions with third party entities as well as intercompany transactions. The foreign currency forwards and swaps are not designated as hedges under FASB ASC Topic 815, Derivatives and Hedging ("FASB ASC Topic 815"). Gains and losses on foreign currency forwards and swaps entered into to offset foreign exchange impacts on intercompany balances are classified as Other income (expense), net, in the unaudited interim consolidated statements of operations. Gains and losses on foreign currency forwards and swaps entered into to offset foreign exchange impacts on all other assets and liabilities are classified as Foreign exchange gain (loss), net, in the unaudited interim consolidated statements of operations.

20



Gross notional values of the foreign currency forwards and swaps are as follows:
 
As of
 
As of
 
September 30,
2012
 
December 31,
2011
 
(In $ millions)
Total
858

 
896


Commodity Risk Management
The Company has exposure to the prices of commodities in its procurement of certain raw materials. The Company manages its exposure to commodity risk primarily through the use of long-term supply agreements, multi-year purchasing and sales agreements and forward purchase contracts. The Company regularly assesses its practice of using forward purchase contracts and other raw material hedging instruments in accordance with changes in economic conditions. Forward purchases and swap contracts for raw materials are principally settled through physical delivery of the commodity. For qualifying contracts, the Company has elected to apply the normal purchases and normal sales exception of FASB ASC Topic 815 based on the probability at the inception and throughout the term of the contract that the Company would not settle net and the transaction would result in the physical delivery of the commodity. As such, realized gains and losses on these contracts are included in the cost of the commodity upon the settlement of the contract.
In addition, the Company occasionally enters into financial derivatives to hedge a component of a raw material or energy source. Typically, these types of transactions do not qualify for hedge accounting. These instruments are marked to market at each reporting period and gains (losses) are included in Cost of sales in the unaudited interim consolidated statements of operations. The Company recognized no gain or loss from these types of contracts during nine months ended September 30, 2012 and 2011. As of September 30, 2012, the Company did not have any open financial derivative contracts for commodities.

Information regarding changes in the fair value of the Company’s derivative arrangements is as follows:
 
Three Months Ended
 
Three Months Ended
 
 
September 30, 2012
 
September 30, 2011
 
 
Gain (Loss)
Recognized in
Other
Comprehensive
Income (Loss)
 
Gain (Loss)
Recognized in
Earnings (Loss)
 
Gain (Loss)
Recognized in
Other
Comprehensive
Income (Loss)
 
Gain (Loss)
Recognized in
Earnings (Loss)
 
 
(In $ millions)
Derivatives Designated as Cash Flow Hedges
 

 
 

 
 

 
 

 
Interest rate swaps
(6
)
 
(4
)
(1) 
(9
)
(2) 
(15
)
(1) 
Derivatives Not Designated as Hedges
 

 
 

 
 

 
 

 
Interest rate swaps

 

(3) 

 
1

(3) 
Foreign currency forwards and swaps

 
(13
)
(4) 

 
17

(4) 
Total
(6
)
 
(17
)
 
(9
)
 
3

 
______________________________
(1) 
Amount represents reclassification from Accumulated other comprehensive income (loss), net and is included in Interest expense in the unaudited interim consolidated statements of operations.
(2) 
Amount excludes $2 million of gains associated with the Company's equity method investments' derivative activity and $2 million of tax expense recognized in Other comprehensive income (loss).
(3) 
Included in Interest expense in the unaudited interim consolidated statements of operations.
(4) 
Included in Foreign exchange gain (loss), net for operating activity or Other income (expense), net for non-operating activity in the unaudited interim consolidated statements of operations.

21



 
Nine Months Ended
 
Nine Months Ended
 
 
September 30, 2012
 
September 30, 2011
 
 
Gain (Loss)
Recognized in
Other
Comprehensive
Income (Loss)
 
Gain (Loss)
Recognized in
Earnings (Loss)
 
Gain (Loss)
Recognized in
Other
Comprehensive
Income (Loss)
 
Gain (Loss)
Recognized in
Earnings (Loss)
 
 
(In $ millions)
Derivatives Designated as Cash Flow Hedges
 

 
 

  
 

 
 

 
Interest rate swaps
(12
)
 
(11
)
(1) 
(26
)
(2) 
(45
)
(1) 
Derivatives Not Designated as Hedges
 

 
 

 
 

 
 

 
Interest rate swaps

 

(3) 

 
(2
)
(3) 
Foreign currency forwards and swaps

 

(4) 

 
2

(4) 
Total
(12
)
 
(11
)
 
(26
)
 
(45
)
 
______________________________
(1) 
Amount represents reclassification from Accumulated other comprehensive income (loss), net and is included in Interest expense in the unaudited interim consolidated statements of operations.
(2) 
Amount excludes $1 million of gains associated with the Company's equity method investments' derivative activity and $8 million of tax expense recognized in Other comprehensive income (loss).
(3) 
Included in Interest expense in the unaudited interim consolidated statements of operations.
(4) 
Included in Foreign exchange gain (loss), net for operating activity or Other income (expense), net for non-operating activity in the unaudited interim consolidated statements of operations.
See Note 16, Fair Value Measurements, for additional information regarding the fair value of the Company’s derivative arrangements.
16. Fair Value Measurements
The Company follows the provisions of FASB ASC Topic 820 for financial assets and liabilities. FASB ASC Topic 820 establishes a three-tiered fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation.
The three levels of inputs are defined as follows:
Level 1 - unadjusted quoted prices for identical assets or liabilities in active markets accessible by the Company
Level 2 - inputs that are observable in the marketplace other than those inputs classified as Level 1
Level 3 - inputs that are unobservable in the marketplace and significant to the valuation
The Company’s financial assets and liabilities are measured at fair value on a recurring basis and include securities available for sale and derivative financial instruments. Securities available for sale include mutual funds. Derivative financial instruments include interest rate swaps and foreign currency forwards and swaps.
Marketable Securities. Where possible, the Company utilizes quoted prices in active markets to measure equity securities; such items are classified as Level 1 in the hierarchy and include mutual funds. Mutual funds are valued at the net asset value per share or unit multiplied by the number of shares or units held as of the measurement date.
Derivatives. Derivative financial instruments are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the hierarchy.

22



Assets and liabilities measured at fair value on a recurring basis are as follows:
 
 
 
Fair Value Measurement Using
 
Balance Sheet Classification
 
Quoted Prices in Active Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Total
 
 
 
(In $ millions)
Mutual funds
Marketable securities, at fair value
 
56

 

 
56

Derivatives Not Designated as Hedges
 
 
 
 
 
 
 
Foreign currency forwards and swaps
Current other assets
 

 
1

 
1

Total assets as of September 30, 2012
 
56

 
1

 
57

Derivatives Designated as Cash Flow Hedges
 
 
 

 
 

 
 

Interest rate swaps
Current other liabilities
 

 
(15
)
 
(15
)
Interest rate swaps
Noncurrent other liabilities
 

 
(12
)
 
(12
)
Derivatives Not Designated as Hedges
 
 
 
 
 
 
 
Foreign currency forwards and swaps
Current other liabilities
 

 
(4
)
 
(4
)
Total liabilities as of September 30, 2012
 

 
(31
)
 
(31
)
 
 
 
 
 
 
 
 
Mutual funds
Marketable securities, at fair value
 
64

 

 
64

Derivatives Not Designated as Hedges
 
 


 


 


Foreign currency forwards and swaps
Current other assets
 

 
9

 
9

Total assets as of December 31, 2011
 
64

 
9

 
73

Derivatives Designated as Cash Flow Hedges
 
 
 

 
 

 
 

Interest rate swaps
Current other liabilities
 

 
(21
)
 
(21
)
Interest rate swaps
Noncurrent other liabilities
 

 
(13
)
 
(13
)
Derivatives Not Designated as Hedges
 
 
 
 
 
 
 
  Interest rate swaps
Current other liabilities
 

 
(2
)
 
(2
)
Foreign currency forwards and swaps
Current other liabilities
 

 
(3
)
 
(3
)
Total liabilities as of December 31, 2011
 

 
(39
)
 
(39
)

23



Carrying values and fair values of financial instruments that are not carried at fair value are as follows:
 
 
 
Fair Value Measurement Using
 
Carrying Amount
 
Significant Other
Observable Inputs
(Level 2)
 
Unobservable Inputs
(Level 3)
 
Total
 
 
 
(In $ millions)
As of September 30, 2012
 
 
 
 
 
 
 
Cost investments
155

 

 

 

Insurance contracts in nonqualified trusts
66

 
66

 

 
66

Long-term debt, including current installments of long-term debt
2,881

 
2,749

 
237

 
2,986

As of December 31, 2011
 
 
 
 
 
 
 
Cost investments
147

 

 

 

Insurance contracts in nonqualified trusts
69

 
69

 

 
69

Long-term debt, including current installments of long-term debt
2,911

 
2,719

 
248

 
2,967

In general, the cost investments included in the table above are not publicly traded and their fair values are not readily determinable; however, the Company believes the carrying values approximate or are less than the fair values. Insurance contracts in nonqualified trusts consist of long-term fixed income securities, which are valued using independent vendor pricing models with observable inputs in the active market and therefore represent a Level 2 measurement. The fair value of long-term debt is based on valuations from third-party banks and market quotations and is classified as Level 2 in the hierarchy. The fair value of obligations under capital leases is based on lease payments and discount rates, which are not observable in the market and therefore represents a Level 3 measurement.
As of September 30, 2012 and December 31, 2011, the fair values of cash and cash equivalents, receivables, trade payables, short-term borrowings and the current installments of long-term debt approximate carrying values due to the short-term nature of these instruments. These items have been excluded from the table with the exception of the current installments of long-term debt. Additionally, certain noncurrent receivables, principally insurance recoverables, are carried at net realizable value.
17. Commitments and Contingencies
The Company is involved in legal and regulatory proceedings, lawsuits and claims incidental to the normal conduct of business, relating to such matters as product liability, land disputes, contracts, antitrust, intellectual property, workers' compensation, chemical exposure, asbestos exposure, prior acquisitions and divestitures, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where the Company is named as a defendant. Due to the inherent subjectivity of assessments and unpredictability of outcomes of legal proceedings, the Company's litigation accruals and estimates of possible loss or range of possible loss ("Possible Loss") may not represent the ultimate loss to the Company from legal proceedings. For reasonably possible loss contingencies that may be material and when determinable, the Company estimates its Possible Loss, considering that the Company could incur no loss in certain matters. Thus, the Company's exposure and ultimate losses may be higher or lower, and possibly materially so, than the Company's litigation accruals and estimates of Possible Loss. For some matters, the Company is unable, at this time, to estimate its Possible Loss that is reasonably possible of occurring. Generally, the less progress that has been made in the proceedings or the broader the range of potential results, the more difficult for the Company to estimate the Possible Loss that it is reasonably possible the Company could incur. The Company may disclose certain information related to a plaintiff's claim against the Company alleged in the plaintiff's pleadings or otherwise publicly available. While information of this type may provide insight into the potential magnitude of a matter, it does not necessarily represent the Company's estimate of reasonably possible or probable loss. Some of the Company's exposure in legal matters may be offset by applicable insurance coverage. The Company does not consider the possible availability of insurance coverage in determining the amounts of any accruals or any estimates of Possible Loss.
Plumbing Actions
CNA Holdings LLC ("CNA Holdings"), a US subsidiary of the Company, which included the US business now in the Advanced Engineered Materials segment, along with Shell Oil Company ("Shell"), E.I. DuPont de Nemours and Company ("DuPont") and others, has been a defendant in a series of lawsuits, including a number of class actions, alleging that plastic resins manufactured by these companies that were utilized by others in the production of plumbing systems for residential

24



property were defective for this use and/or contributed to the failure of such plumbing. Based on, among other things, the findings of outside experts and the successful use of the Company's acetal copolymer in similar applications, CNA Holdings does not believe the Company's acetal copolymer was defective for this use or contributed to the failure of the plumbing. In addition, in many cases CNA Holdings' potential future exposure may be limited by, among other things, statutes of limitations and repose.
In November 1995, CNA Holdings, DuPont and Shell entered into national class action settlements in the Cox, et al. v. Hoechst Celanese Corporation, et al., No. 94-0047 (Chancery Ct., Obion County, Tennessee) matter. The time to file claims against the class has expired and the entity established by the court to administer the claims was dissolved in September 2010. In addition between 1995 and 2001, CNA Holdings was named as a defendant in various putative class actions. The majority of these actions have now been dismissed. As a result the Company recorded $59 million in reserve reductions and recoveries from associated insurance indemnifications during 2010. The reserve was further reduced by $4 million during the year ended December 31, 2011 following the dismissal of the remaining US case (St. Croix, Ltd., et al. v. Shell Oil Company d/b/a Shell Chemical Company, Case No. XC-97-CR-467, Virgin Islands Superior Court) which was appealed during the three months ended September 30, 2011.
As of September 30, 2012, the class actions in Canada are subject to a pending class settlement that would result in a dismissal of those cases. The Company does not believe the Possible Loss associated with the remaining matters is material. Accordingly, the Company has determined to reduce the reserves based on the expiration of the time to file and the resolution of certain claims under the Canada class and no significant active claims outside of Canada. The Company recorded recoveries and reductions in legal reserves related to plumbing actions to Other (charges) gains, net (Note 13) in the unaudited interim consolidated statements of operations as follows:
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2012
 
2011
 
2012
 
2011
 
(In $ millions)
Recoveries

 

 

 
2

Legal reserve reductions
4

 
2

 
4

 
4

Total
4

 
2

 
4

 
6

Polyester Staple Antitrust Litigation
CNA Holdings, the successor in interest to Hoechst Celanese Corporation ("HCC"), Celanese Americas Corporation and Celanese GmbH (collectively, the "Celanese Entities") and Hoechst, the former parent of HCC, were named as defendants in two actions (involving multiple individual participants) filed in September 2006 by US purchasers of polyester staple fibers manufactured and sold by HCC. The actions alleged that the defendants participated in a conspiracy to fix prices, rig bids and allocate customers of polyester staple sold in the US. These actions were consolidated in a proceeding by a Multi-District Litigation Panel in the US District Court for the Western District of North Carolina styled In re Polyester Staple Antitrust Litigation, MDL 1516. On June 12, 2008 the court dismissed these actions with prejudice against all Celanese Entities in consideration of a payment by the Company. This proceeding related to sales by the polyester staple fibers business which Hoechst sold to KoSa B.V., f/k/a Arteva B.V., a subsidiary of Koch Industries, Inc. ("KoSa") in 1998. In November 2003, KoSa sought recovery from the Company (Koch Industries, Inc. et al. v. Hoechst Aktiengesellschaft et al., No. 03-cv-8679 Southern District NY) alleging a variety of claims, including indemnification and breach of representations, arising out of the 1998 sale. During the fourth quarter of 2010, the parties settled the case pursuant to a confidential agreement and the case was dismissed with prejudice.
Prior to December 31, 2008, the Company had entered into tolling arrangements with four other alleged US purchasers of polyester staple fibers manufactured and sold by the Celanese Entities. These purchasers were not included in the settlement and one such company filed suit against the Company in December 2008 (Milliken & Company v. CNA Holdings, Inc., Celanese Americas Corporation and Hoechst AG (No. 8-SV-00578 W.D.N.C.)). On September 15, 2011, the case was dismissed with prejudice based on a stipulation and proposed order of voluntary dismissal.
Commercial Actions
In April 2007, Southern Chemical Corporation ("Southern") filed a petition in the 190th Judicial District Court of Harris County, Texas styled Southern Chemical Corporation v. Celanese Ltd. (Cause No. 2007-25490), seeking declaratory judgment relating to the terms of a multi-year methanol supply contract. The trial court granted the Company's motion for summary

25



judgment in March 2008 dismissing Southern's claims. In September 2009, the intermediate Texas appellate court reversed the trial court decision and remanded the case to the trial court. The Texas Supreme Court subsequently declined both parties' requests that it hear the case. On August 15, 2010, Southern filed a second amended petition adding a claim for breach of contract and seeking equitable damages in an unspecified amount from the Company. Southern amended its complaint again in June, August and November 2011 and May 2012, adding new claims for fraud and tortious interference with a third-party contract. More specifically, Southern claimed the Company "materially misrepresented its intended use of the methanol to be supplied by Southern" and "violated the material terms of the contract and failed to correct these breaches after Southern provided notice." These alleged breaches include "selling, transferring, swapping or tolling methanol to or with entities other than the Company and to entities or operations outside the U.S. or Mexico." In the May 2012 complaint, Southern sought compensatory damages of $1.3 billion, as well as pre- and post-judgment interest, attorneys' fees and punitive damages equaling two times its actual damages. Southern also sought rescission or termination of the contract. Trial commenced on July 16, 2012, and on August 10, 2012, the jury returned a verdict of no liability and no damages with respect to all of Southern's claims against the Company. The trial court adopted the jury's verdict and entered final judgment on October 10, 2012. Southern may file a motion for new trial and/or seek appeal.
In June 2012, Linde Gas Singapore Pte Ltd ("Linde Gas"), a raw materials supplier based in Singapore, initiated arbitration proceedings in New York against the Company's subsidiary, Celanese Singapore Pte. Ltd. ("Singapore Ltd."), alleging that Singapore Ltd. had breached a certain requirements contract for carbon monoxide by temporarily idling Singapore Ltd.'s acetic acid facility in Jurong Island, Singapore. The Company filed its answer on August 8, 2012. The Company believes that Linde Gas' claims lack merit and that the Company has complied with the contract terms and plans to vigorously defend the matter. Based on the Company's evaluation of currently available information, the Company cannot estimate the Possible Loss, if any, for this matter as discovery has not yet commenced and Linde Gas' arbitration demand does not specify an amount of damages it is seeking.
Award Proceedings in relation to Domination Agreement and Squeeze-Out
The Company's subsidiary, BCP Holdings GmbH ("BCP Holdings"), a German limited liability company, is a defendant in two special award proceedings initiated by minority stockholders of Celanese GmbH seeking the court's review of the amounts (i) of the fair cash compensation and of the guaranteed dividend offered in the purchaser offer under the 2004 Domination Agreement (the "Domination Agreement") and (ii) the fair cash compensation paid for the 2006 squeeze-out ("Squeeze-Out") of all remaining stockholders of Celanese GmbH.
Pursuant to a settlement agreement between BCP Holdings and certain former Celanese GmbH stockholders, if the court sets a higher value for the fair cash compensation or the guaranteed payment under the Domination Agreement or the Squeeze-Out compensation, former Celanese GmbH stockholders who ceased to be stockholders of Celanese GmbH due to the Squeeze-Out will be entitled to claim for their shares the higher of the compensation amounts determined by the court in these different proceedings related to the Domination Agreement and the Squeeze-Out. If the fair cash compensation determined by the court is higher than the Squeeze-Out compensation of €66.99, then 1,069,465 shares will be entitled to an adjustment. If the court determines the value of the fair cash compensation under the Domination Agreement to be lower than the original Squeeze-Out compensation, but determines a higher value for the Squeeze-Out compensation, 924,078 shares would be entitled to an adjustment. Payments already received by these stockholders as compensation for their shares will be offset so that persons who ceased to be stockholders of Celanese GmbH due to the Squeeze-Out are not entitled to more than the higher of the amount set in the two court proceedings.
In September 2011, an expert appointed by the court hearing the Domination Agreement stockholders' claims to assist it in determining the value of Celanese GmbH rendered an opinion. The expert opined that the fair cash compensation for these stockholders (145,387 shares) should be increased from €41.92 to €51.86. This non-binding opinion recommends a total increase in share value to €2 million for those claims under the Domination Agreement. The opinion has no effect on the Squeeze-Out proceeding because the share price recommended is lower than the price those stockholders already received in the Squeeze-Out. However, the opinion also advocates that the guaranteed dividend should be increased from €2.89 to €3.79, aggregating an increase in total guaranteed dividends of €1 million to the Squeeze-Out claimants. The Company evaluated the non-binding opinion of the expert and submitted a written response during the three months ended December 31, 2011. The court then asked the expert to update his opinion. No hearing date has been set. No expert has yet been appointed in the Squeeze-Out proceedings.
For those claims brought under the Domination Agreement, based on the Company's evaluation of currently available information, including the non-binding expert opinion, the fact that the court has asked the expert to update his opinion, and the fact that the court may adopt this new opinion or apply its own (there are legal questions about the applicable valuation

26



method), which could increase or decrease the Company's potential exposure, the Company does not believe that the Possible Loss is material.
For those remaining claims brought by the Squeeze-Out claimants, based on the Company's evaluation of currently available information, including that damages sought are unspecified, unsupported or uncertain, the matter presents meaningful legal uncertainties (including novel issues of law and the applicable valuation method), there are significant facts in dispute and the court has not yet appointed an expert, the Company cannot estimate the Possible Loss, if any, at this time.
Guarantees
The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations.
As indemnification obligations often depend on the occurrence of unpredictable future events, the future costs associated with them cannot be determined at this time.
The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims that have been brought to its attention. These known obligations include the following:
Demerger Obligations
In connection with the Hoechst demerger, the Company agreed to indemnify Hoechst, and its legal successors, for various liabilities under the demerger agreement, including for environmental liabilities associated with contamination arising either from environmental damage in general ("Category A") or under 19 divestiture agreements entered into by Hoechst prior to the demerger ("Category B") (Note 11).
The Company's obligation to indemnify Hoechst, and its legal successors, is capped under Category B at €250 million. If and to the extent the environmental damage should exceed €750 million in aggregate, the Company's obligation to indemnify Hoechst and its legal successors applies, but is then limited to 33.33% of the remediation cost without further limitations. Cumulative payments under the divestiture agreements as of September 30, 2012 are $58 million. Most of the divestiture agreements have become time barred and/or any notified environmental damage claims have been partially settled.
The Company has also undertaken in the demerger agreement to indemnify Hoechst and its legal successors for (i) 33.33% of any and all Category A liabilities that result from Hoechst being held as the responsible party pursuant to public law or current or future environmental law or by third parties pursuant to private or public law related to contamination and (ii) liabilities that Hoechst is required to discharge, including tax liabilities, which are associated with businesses that were included in the demerger but were not demerged due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not been requested by Hoechst to make any payments in connection with this indemnification. Accordingly, the Company has not made any payments to Hoechst or its legal successors.
Based on the Company's evaluation of currently available information, including the lack of requests for indemnification, the Company cannot estimate the Possible Loss for the remaining demerger obligations, if any, in excess of amounts accrued.
Divestiture Obligations
The Company and its predecessor companies agreed to indemnify third-party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to any significant risk (Note 11).
The Company has divested numerous businesses, investments and facilities through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, ranging from one year to thirty years. The aggregate amount of outstanding indemnifications and guarantees provided for under these agreements is $193 million as of September 30, 2012. Other agreements do not provide for any monetary or time limitations.

27



Based on the Company's evaluation of currently available information, including the number of requests for indemnification or other payment received by the Company, the Company cannot estimate the Possible Loss for the remaining divestiture obligations, if any, in excess of amounts accrued.
Purchase Obligations
In the normal course of business, the Company enters into various purchase commitments for goods and services which extend through 2034. The Company maintains a number of "take-or-pay" contracts for purchases of raw materials, utilities and other services. Certain of the contracts contain a contract termination buy-out provision that allows for the Company to exit the contracts for amounts less than the remaining take-or-pay obligations. The Company does not expect to incur any material costs under take-or-pay contracts as a result of not fulfilling its contractual obligations. Additionally, the Company has other outstanding commitments representing maintenance and service agreements, energy and utility agreements, consulting contracts and software agreements. As of September 30, 2012, the Company had unconditional purchase obligations of $3.5 billion.
The Company holds variable interests in entities that supply certain raw materials and services to the Company. The variable interests primarily relate to cost-plus contractual arrangements with the suppliers and recovery of capital expenditures for certain plant assets plus a rate of return on such assets. The Company recorded obligations under capital leases for recovery of the capital expenditures. The entities are not consolidated because the Company is not the primary beneficiary of the entities as it does not have the power to direct the activities of the entities that most significantly impact the entities' economic performance. The Company's maximum exposure to loss as a result of its involvement with these variable interest entities ("VIEs") as of September 30, 2012 relates primarily to early contract termination fees.
The Company's carrying value of assets and liabilities associated with its obligations to VIEs, as well as the maximum exposure to loss relating to these VIEs are as follows:
 
As of
 
As of
 
September 30,
2012
 
December 31,
2011
 
(In $ millions)
Property, plant and equipment, net
116
 
119
 
 
 
 
Trade payables
37
 
40
Current installments of long-term debt
7
 
6
Long-term debt
136
 
137
Total
180
 
183
 
 
 
 
Maximum exposure to loss
282
 
228
The difference between the total obligations to VIEs and the maximum exposure to loss, primarily represents take-or-pay obligations for services included within the unconditional obligations discussed above.
During March 2010, the Company successfully completed an amended raw material purchase agreement with a supplier who had filed for bankruptcy. During nine months ended September 30, 2011, the Company received consideration of $17 million in connection with the settlement of a claim against this bankrupt supplier. The consideration was recorded to Other charges (gains), net (Note 13) in the unaudited interim consolidated statements of operations.

28



18. Segment Information
 
Advanced
Engineered
Materials
 
Consumer
Specialties
 
Industrial
Specialties
 
Acetyl
Intermediates
 
Other
Activities
 
Eliminations
 
Consolidated
 
 
(In $ millions)
 
Three Months Ended September 30, 2012
Net sales
322

 
314

(1) 
297

 
785

(1) 

 
(109
)
 
1,609

 
Other (charges) gains, net
1

 
(1
)
 

 
1

 
1

 

 
2

 
Operating profit (loss)
43

 
70

  
23

 
62

 
(35
)
 

 
163

 
Equity in net earnings (loss) of affiliates
45

 

  

 

 
5

 

 
50

 
Depreciation and amortization
29

 
13

  
13

 
20

 
3

 

 
78

 
Capital expenditures
11

 
14

  
9

 
47

 
2

 

 
83

(2) 
 
Three Months Ended September 30, 2011
Net sales
332

 
298

(1) 
332

 
975

(1) 

 
(130
)
 
1,807

  
Other (charges) gains, net
(13
)
 
2

 

 
(5
)
 
(8
)
 

 
(24
)
 
Operating profit (loss)
14

 
66

 
30

 
128

  
(42
)
 

 
196

 
Equity in net earnings (loss) of affiliates
52

 
1

  

 
1

  
3

 

 
57

 
Depreciation and amortization
27

 
9

  
12

 
25

 
4

 

 
77

 
Capital expenditures
13

 
24

  
20

 
39

  
3

 

 
99

(2) 
______________________________
(1) 
Net sales for Acetyl Intermediates and Consumer Specialties include inter-segment sales of $109 million and $0 million, respectively, for the three months ended September 30, 2012 and $129 million and $1 million, respectively, for the three months ended September 30, 2011.
(2) 
Excludes expenditures related to the relocation of the Company’s POM operations in Germany (Note 20) and includes a decrease in accrued capital expenditures of $4 million and an increase of $9 million for the three months ended September 30, 2012 and 2011, respectively.

29



 
Advanced
Engineered
Materials
 
Consumer
Specialties
 
Industrial
Specialties
 
Acetyl
Intermediates
 
Other
Activities
 
Eliminations
 
Consolidated
 
 
(In $ millions)
 
Nine Months Ended September 30, 2012
Net sales
962

 
905

(1) 
933

 
2,458

(1) 

 
(341
)
 
4,917

 
Other (charges) gains, net
(1
)
 
2

 

 
2

 
(4
)
 

 
(1
)
 
Operating profit (loss)
85

 
184

  
76

 
199

 
(119
)
 

 
425

 
Equity in net earnings (loss) of affiliates
143

 
2

  

 
3

 
15

 

 
163

 
Depreciation and amortization
84

 
33

  
41

 
59

 
10

 

 
227

 
Capital expenditures
28

 
48

  
25

 
122

 
13

 

 
236

(2) 
 
As of September 30, 2012
Goodwill and intangibles, net
374

 
275

 
67

 
226

 

 

 
942

 
Total assets
2,728

 
1,302

 
994

 
2,171

 
1,770

 

 
8,965

 
 
Nine Months Ended September 30, 2011
Net sales
1,006

 
855

(1) 
951

 
2,702

(1) 
1

 
(366
)
 
5,149

  
Other (charges) gains, net
(42
)
 
(2
)
 

 
15

 
(10
)
 

 
(39
)
 
Operating profit (loss)
79

 
168

 
83

 
392

  
(129
)
 

 
593

 
Equity in net earnings (loss) of affiliates
125

 
2

  

 
4

  
15

 

 
146

 
Depreciation and amortization
68

 
34

  
34

 
75

 
10

 

 
221

 
Capital expenditures
50

 
59

  
44

 
79

  
7

 

 
239

(2) 
 
As of December 31, 2011
Goodwill and intangibles, net
391

 
277

 
54

 
235

 

 

 
957

 
Total assets
2,787

 
1,154

 
901

 
2,035

 
1,641

 

 
8,518

 
______________________________
(1) 
Net sales for Acetyl Intermediates and Consumer Specialties include inter-segment sales of $338 million and $3 million, respectively, for the nine months ended September 30, 2012 and $363 million and $3 million, respectively, for the nine months ended September 30, 2011.
(2) 
Excludes expenditures related to the relocation of the Company’s POM operations in Germany (Note 20) and includes a decrease in accrued capital expenditures of $34 million and $2 million for the nine months ended September 30, 2012 and 2011, respectively.
19. Earnings (Loss) Per Share

 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2012
 
2011
 
2012
 
2011
 
(In $ millions, except share and per share data)
Amounts Attributable to Celanese Corporation
 
 
 
 
 
 
 
Earnings (loss) from continuing operations
119

 
167

 
512

 
510

Earnings (loss) from discontinued operations
(2
)
 

 
(2
)
 
2

Net earnings (loss) available to common stockholders
117

 
167

 
510

 
512

 
 
 
 
 
 
 
 
Weighted-average shares - basic
159,123,808

 
156,194,459

 
157,936,063

 
156,147,982

Dilutive stock options
292,661

 
1,898,195

 
1,054,012

 
1,975,911

Dilutive restricted stock units
678,435

 
926,185

 
654,091

 
841,918

Weighted-average shares - diluted
160,094,904

 
159,018,839

 
159,644,166

 
158,965,811



30



Securities not included in the computation of diluted net earnings per share as their effect would have been antidilutive are as follows:
 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2012
 
2011
 
2012
 
2011
Stock options
30,032

 

 
15,016

 
60,208

Restricted stock units
92

 
1,008

 
5,328

 
336

Total
30,124

 
1,008

 
20,344

 
60,544

20. Plant Relocation
In November 2006, the Company finalized a settlement agreement with the Frankfurt, Germany Airport ("Fraport") that required the Company to cease operations at its Kelsterbach, Germany POM site and sell the site, including land and buildings, to Fraport, resolving several years of legal disputes related to the planned Fraport expansion. Under the original agreement, Fraport agreed to pay the Company a total of €670 million. The agreement requires the Company to complete certain activities no later than December 31, 2013 at which time title to the land and buildings will transfer to Fraport. The agreement did not require the proceeds from the settlement be used to build or relocate the existing POM operations; however, based on a number of factors, the Company built a new expanded production facility in the Frankfurt Hoechst Industrial Park in the Rhine Main area in Germany.
The Company received its final payment from Fraport of €110 million during the three months ended June 30, 2011 and ceased POM operations at the Kelsterbach, Germany site prior to July 31, 2011. In September 2011, the Company announced the opening of its new POM production facility in Frankfurt Hoechst Industrial Park, Germany.
A summary of the financial statement impact associated with the Kelsterbach plant relocation is as follows:
 
Nine Months Ended
 
Total From
Inception Through
 
September 30,
 
 
2012
 
2011
 
September 30, 2012
 
(In $ millions)
Deferred proceeds (1)

 
158

 
907

Costs expensed
5

 
43

 
111

Costs capitalized (2)
30

 
137

 
1,122

Lease buyout

 

 
22

Employee termination benefits

 
5

 
8

_____________________________
(1) 
Included in noncurrent Other liabilities in the consolidated balance sheets. Amounts reflect the US dollar equivalent at the time of receipt. Upon transfer of title to Fraport, the deferred proceeds will be recognized in the consolidated statements of operations. Such proceeds will be reduced by assets of €38 million included in Property, plant and equipment, net and €70 million included in noncurrent Other assets in the consolidated balance sheets, to be transferred to Fraport or otherwise disposed.
(2) 
Includes a decrease in accrued capital expenditures of $13 million and $37 million for the nine months ended September 30, 2012 and 2011, respectively.
21. Consolidating Guarantor Financial Information
The 6.625% Notes and the 5.875% Notes (collectively, the "Notes") were issued by Celanese US (the "Issuer") and are guaranteed by Celanese Corporation (the "Parent Guarantor") and the Subsidiary Guarantors (Note 9). The Issuer and Subsidiary Guarantors are 100% owned subsidiaries of the Parent Guarantor. The Parent Guarantor and Subsidiary Guarantors have guaranteed the Notes fully and unconditionally and jointly and severally.
For cash management purposes, the Company transfers cash between Parent Guarantor, Issuer, Subsidiary Guarantors and non-guarantors through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. The transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments. As a result, the Company presents such intercompany financing activities, contributions and dividends within the category where the ultimate use of cash to third parties is presented in the accompanying unaudited interim

31



consolidated statements of cash flows.
The Company has not presented separate financial information and other disclosures for each of its Subsidiary Guarantors because it believes such financial information and other disclosures would not provide investors with any additional information that would be material in evaluating the sufficiency of the guarantees.
The unaudited interim consolidating financial statements for the Parent Guarantor, the Issuer, the Subsidiary Guarantors and the non-guarantors are as follows:
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATING STATEMENTS OF OPERATIONS
 
Three Months Ended September 30, 2012
 
Parent
Guarantor
 
Issuer
 
Subsidiary
Guarantors
 
Non-
Guarantors
 
Eliminations
 
Consolidated
 
(In $ millions)
Net sales

 

 
670

 
1,196

 
(257
)
 
1,609

Cost of sales

 

 
(471
)
 
(1,079
)
 
265

 
(1,285
)
Gross profit

 

 
199

 
117

 
8

 
324

Selling, general and administrative expenses

 

 
(41
)
 
(80
)
 

 
(121
)
Amortization of intangible assets

 

 
(4
)
 
(8
)
 

 
(12
)
Research and development expenses

 

 
(17
)
 
(7
)
 

 
(24
)
Other (charges) gains, net

 

 
6

 
(4
)
 

 
2

Foreign exchange gain (loss), net

 

 

 
(4
)
 

 
(4
)
Gain (loss) on disposition of businesses and assets, net

 

 
(1
)
 
(1
)
 

 
(2
)
Operating profit (loss)

 

 
142

 
13

 
8

 
163

Equity in net earnings (loss) of affiliates
116

 
141

 
44

 
37

 
(288
)
 
50

Interest expense

 
(48
)
 
(10
)
 
(18
)
 
32

 
(44
)
Refinancing expense

 

 

 

 

 

Interest income

 
14

 
16

 
2

 
(32
)
 

Dividend income - cost investments

 

 

 
1

 

 
1

Other income (expense), net

 
(1
)
 

 
4

 

 
3

Earnings (loss) from continuing operations before tax
116

 
106

 
192

 
39

 
(280
)
 
173

Income tax (provision) benefit
1

 
10

 
(55
)
 
(8
)
 
(2
)
 
(54
)
Earnings (loss) from continuing operations
117

 
116

 
137

 
31

 
(282
)
 
119

Earnings (loss) from operation of discontinued operations

 

 
(2
)
 
(1
)
 

 
(3
)
Gain (loss) on disposition of discontinued operations

 

 

 

 

 

Income tax (provision) benefit from discontinued operations

 

 
1

 

 

 
1

Earnings (loss) from discontinued operations

 

 
(1
)
 
(1
)
 

 
(2
)
Net earnings (loss)
117

 
116

 
136

 
30

 
(282
)
 
117

Net (earnings) loss attributable to noncontrolling interests

 

 

 

 

 

Net earnings (loss) attributable to Celanese Corporation
117

 
116

 
136

 
30

 
(282
)
 
117


32



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATING STATEMENTS OF OPERATIONS
 
Three Months Ended September 30, 2011
 
Parent
Guarantor
 
Issuer
 
Subsidiary
Guarantors
 
Non-
Guarantors
 
Eliminations
 
Consolidated
 
(In $ millions)
Net sales

 

 
662

 
1,401

 
(256
)
 
1,807

Cost of sales

 

 
(491
)
 
(1,184
)
 
269

 
(1,406
)
Gross profit

 

 
171

 
217

 
13

 
401

Selling, general and administrative expenses

 

 
(31
)
 
(109
)
 

 
(140
)
Amortization of intangible assets

 

 
(5
)
 
(12
)
 

 
(17
)
Research and development expenses

 

 
(16
)
 
(8
)
 

 
(24
)
Other (charges) gains, net

 

 
(5
)
 
(19
)
 

 
(24
)
Foreign exchange gain (loss), net

 

 

 
1

 

 
1

Gain (loss) on disposition of businesses and assets, net

 

 
(1
)
 

 

 
(1
)
Operating profit (loss)

 

 
113

 
70

 
13

 
196

Equity in net earnings (loss) of affiliates
167

 
205

 
70

 
45

 
(430
)
 
57

Interest expense

 
(53
)
 
(9
)
 
(10
)
 
18

 
(54
)
Refinancing expense

 

 

 

 

 

Interest income

 
5

 
12

 
2

 
(18
)
 
1

Dividend income - cost investments

 

 

 
1

 

 
1

Other income (expense), net

 
(1
)
 

 
1

 

 

Earnings (loss) from continuing operations before tax
167

 
156

 
186

 
109

 
(417
)
 
201

Income tax (provision) benefit

 
11

 
(30
)
 
(13
)
 
(2
)
 
(34
)
Earnings (loss) from continuing operations
167

 
167

 
156

 
96

 
(419
)
 
167

Earnings (loss) from operation of discontinued operations

 

 
1

 
(1
)
 

 

Gain (loss) on disposition of discontinued operations

 

 

 

 

 

Income tax (provision) benefit from discontinued operations

 

 

 

 

 

Earnings (loss) from discontinued operations

 

 
1

 
(1
)
 

 

Net earnings (loss)
167

 
167

 
157

 
95

 
(419
)
 
167

Net (earnings) loss attributable to noncontrolling interests

 

 

 

 

 

Net earnings (loss) attributable to Celanese Corporation
167

 
167

 
157

 
95

 
(419
)
 
167



33



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATING STATEMENTS OF OPERATIONS
 
Nine Months Ended September 30, 2012
 
Parent
Guarantor
 
Issuer
 
Subsidiary
Guarantors
 
Non-
Guarantors
 
Eliminations
 
Consolidated
 
(In $ millions)
Net sales

 

 
2,044

 
3,684

 
(811
)
 
4,917

Cost of sales

 

 
(1,473
)
 
(3,340
)
 
821

 
(3,992
)
Gross profit

 

 
571

 
344

 
10

 
925

Selling, general and administrative expenses

 

 
(135
)
 
(244
)
 

 
(379
)
Amortization of intangible assets

 

 
(13
)
 
(25
)
 

 
(38
)
Research and development expenses

 

 
(51
)
 
(25
)
 

 
(76
)
Other (charges) gains, net

 

 
13

 
(8
)
 
(6
)
 
(1
)
Foreign exchange gain (loss), net

 

 

 
(4
)
 

 
(4
)
Gain (loss) on disposition of businesses and assets, net

 

 
(1
)
 
(1
)
 

 
(2
)
Operating profit (loss)

 

 
384

 
37

 
4

 
425

Equity in net earnings (loss) of affiliates
508

 
577

 
134

 
128

 
(1,184
)
 
163

Interest expense

 
(144
)
 
(31
)
 
(55
)
 
96

 
(134
)
Refinancing expense

 

 

 

 

 

Interest income

 
44

 
48

 
5

 
(96
)
 
1

Dividend income - cost investments

 

 

 
85

 

 
85

Other income (expense), net

 

 

 
4

 

 
4

Earnings (loss) from continuing operations before tax
508

 
477

 
535

 
204

 
(1,180
)
 
544

Income tax (provision) benefit
2

 
31

 
(33
)
 
(31
)
 
(1
)
 
(32
)
Earnings (loss) from continuing operations
510

 
508

 
502

 
173

 
(1,181
)
 
512

Earnings (loss) from operation of discontinued operations

 

 
(2
)
 
(1
)
 

 
(3
)
Gain (loss) on disposition of discontinued operations

 

 

 

 

 

Income tax (provision) benefit from discontinued operations

 

 
1

 

 

 
1

Earnings (loss) from discontinued operations

 

 
(1
)
 
(1
)
 

 
(2
)
Net earnings (loss)
510

 
508

 
501

 
172

 
(1,181
)
 
510

Net (earnings) loss attributable to noncontrolling interests

 

 

 

 

 

Net earnings (loss) attributable to Celanese Corporation
510

 
508

 
501

 
172

 
(1,181
)
 
510


34



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATING STATEMENTS OF OPERATIONS
 
Nine Months Ended September 30, 2011
 
Parent
Guarantor
 
Issuer
 
Subsidiary
Guarantors
 
Non-
Guarantors
 
Eliminations
 
Consolidated
 
(In $ millions)
Net sales

 

 
1,937

 
4,012

 
(800
)
 
5,149

Cost of sales

 

 
(1,399
)
 
(3,389
)
 
801

 
(3,987
)
Gross profit

 

 
538

 
623

 
1

 
1,162

Selling, general and administrative expenses

 

 
(111
)
 
(297
)
 

 
(408
)
Amortization of intangible assets

 

 
(14
)
 
(36
)
 

 
(50
)
Research and development expenses

 

 
(46
)
 
(26
)
 

 
(72
)
Other (charges) gains, net

 

 
20

 
(59
)
 

 
(39
)
Foreign exchange gain (loss), net

 

 

 
1

 

 
1

Gain (loss) on disposition of businesses and assets, net

 

 

 
(1
)
 

 
(1
)
Operating profit (loss)

 

 
387

 
205

 
1

 
593

Equity in net earnings (loss) of affiliates
511

 
629

 
125

 
116

 
(1,235
)
 
146

Interest expense

 
(160
)
 
(30
)
 
(29
)
 
53

 
(166
)
Refinancing expense

 
(3
)
 

 

 

 
(3
)
Interest income

 
16

 
31

 
8

 
(53
)
 
2

Dividend income - cost investments

 

 

 
80

 

 
80

Other income (expense), net

 
2

 
(1
)
 
8

 

 
9

Earnings (loss) from continuing operations before tax
511

 
484

 
512

 
388

 
(1,234
)
 
661

Income tax (provision) benefit
1

 
27

 
(123
)
 
(56
)
 

 
(151
)
Earnings (loss) from continuing operations
512

 
511

 
389

 
332

 
(1,234
)
 
510

Earnings (loss) from operation of discontinued operations

 

 
4

 
(1
)
 

 
3

Gain (loss) on disposition of discontinued operations

 

 

 

 

 

Income tax (provision) benefit from discontinued operations

 

 
(1
)
 

 

 
(1
)
Earnings (loss) from discontinued operations

 

 
3

 
(1
)
 

 
2

Net earnings (loss)
512

 
511

 
392

 
331

 
(1,234
)
 
512

Net (earnings) loss attributable to noncontrolling interests

 

 

 

 

 

Net earnings (loss) attributable to Celanese Corporation
512

 
511

 
392

 
331

 
(1,234
)
 
512


35



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
 
Three Months Ended September 30, 2012
 
Parent
Guarantor
 
Issuer
 
Subsidiary
Guarantors
 
Non-
Guarantors
 
Eliminations
 
Consolidated
 
(In $ millions)
Net earnings (loss)
117

 
116

 
136

 
30

 
(282
)
 
117

Other comprehensive income (loss), net of tax
 
 
 
 
 
 
 
 
 
 
 
Unrealized gain (loss) on marketable securities

 

 

 

 

 

Foreign currency translation
28

 
28

 
(5
)
 
(1
)
 
(22
)
 
28

Unrealized gain (loss) on interest rate swaps
(2
)
 
(2
)
 

 

 
2

 
(2
)
Pension and postretirement benefits
10

 
10

 
9

 
1

 
(20
)
 
10

Total other comprehensive income (loss), net of tax
36

 
36

 
4

 

 
(40
)
 
36

Total comprehensive income (loss), net of tax
153

 
152

 
140

 
30

 
(322
)
 
153

Comprehensive (income) loss attributable to noncontrolling interests

 

 

 

 

 

Comprehensive income (loss) attributable to Celanese Corporation
153

 
152

 
140

 
30

 
(322
)
 
153


 
Three Months Ended September 30, 2011
 
Parent
Guarantor
 
Issuer
 
Subsidiary
Guarantors
 
Non-
Guarantors
 
Eliminations
 
Consolidated
 
(In $ millions)
Net earnings (loss)
167

 
167

 
157

 
95

 
(419
)
 
167

Other comprehensive income (loss), net of tax
 
 
 
 
 
 
 
 
 
 
 
Unrealized gain (loss) on marketable securities

 

 

 

 

 

Foreign currency translation
(69
)
 
(69
)
 
13

 
(84
)
 
140

 
(69
)
Unrealized gain (loss) on interest rate swaps
5

 
5

 

 
2

 
(7
)
 
5

Pension and postretirement benefits
4

 
4

 
4

 

 
(8
)
 
4

Total other comprehensive income (loss), net of tax
(60
)
 
(60
)
 
17

 
(82
)
 
125

 
(60
)
Total comprehensive income (loss), net of tax
107

 
107

 
174

 
13

 
(294
)
 
107

Comprehensive (income) loss attributable to noncontrolling interests

 

 

 

 

 

Comprehensive income (loss) attributable to Celanese Corporation
107

 
107

 
174

 
13

 
(294
)
 
107



36



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
 
Nine Months Ended September 30, 2012
 
Parent
Guarantor
 
Issuer
 
Subsidiary
Guarantors
 
Non-
Guarantors
 
Eliminations
 
Consolidated
 
(In $ millions)
Net earnings (loss)
510

 
508

 
501

 
172

 
(1,181
)
 
510

Other comprehensive income (loss), net of tax
 
 
 
 
 
 
 
 
 
 
 
Unrealized gain (loss) on marketable securities

 

 

 

 

 

Foreign currency translation
4

 
4

 
1

 
4

 
(9
)
 
4

Unrealized gain (loss) on interest rate swaps
(1
)
 
(1
)
 

 

 
1

 
(1
)
Pension and postretirement benefits
25

 
25

 
22

 

 
(47
)
 
25

Total other comprehensive income (loss), net of tax
28

 
28

 
23

 
4

 
(55
)
 
28

Total comprehensive income (loss), net of tax
538

 
536

 
524

 
176

 
(1,236
)
 
538

Comprehensive (income) loss attributable to noncontrolling interests

 

 

 

 

 

Comprehensive income (loss) attributable to Celanese Corporation
538

 
536

 
524

 
176

 
(1,236
)
 
538


 
Nine Months Ended September 30, 2011
 
Parent
Guarantor
 
Issuer
 
Subsidiary
Guarantors
 
Non-
Guarantors
 
Eliminations
 
Consolidated
 
(In $ millions)
Net earnings (loss)
512

 
511

 
392

 
331

 
(1,234
)
 
512

Other comprehensive income (loss), net of tax
 
 
 
 
 
 
 
 
 
 
 
Unrealized gain (loss) on marketable securities

 

 

 

 

 

Foreign currency translation
18

 
18

 
3

 
14

 
(35
)
 
18

Unrealized gain (loss) on interest rate swaps
14

 
14

 

 
1

 
(15
)
 
14

Pension and postretirement benefits
12

 
12

 
12

 

 
(24
)
 
12

Total other comprehensive income (loss), net of tax
44

 
44

 
15

 
15

 
(74
)
 
44

Total comprehensive income (loss), net of tax
556

 
555

 
407

 
346

 
(1,308
)
 
556

Comprehensive (income) loss attributable to noncontrolling interests

 

 

 

 

 

Comprehensive income (loss) attributable to Celanese Corporation
556

 
555

 
407

 
346

 
(1,308
)
 
556


37



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED CONSOLIDATING BALANCE SHEETS
 
As of September 30, 2012
 
Parent
Guarantor
 
Issuer
 
Subsidiary
Guarantors
 
Non-
Guarantors
 
Eliminations
 
Consolidated
 
(In $ millions)
ASSETS
 

 
 

 
 

 
 

 
 

 
 

Current Assets
 

 
 

 
 

 
 

 
 

 
 

Cash and cash equivalents
26

 

 
225

 
677

 

 
928

Trade receivables - third party and affiliates

 

 
323

 
723

 
(114
)
 
932

Non-trade receivables, net

 
33

 
1,777

 
489

 
(2,111
)
 
188

Inventories, net

 

 
189

 
584

 
(62
)
 
711

Deferred income taxes

 

 
88

 
18

 

 
106

Marketable securities, at fair value

 

 
56

 

 

 
56

Other assets

 
5

 
19

 
45

 
(22
)
 
47

Total current assets
26

 
38

 
2,677

 
2,536

 
(2,309
)
 
2,968

Investments in affiliates
1,862

 
3,594

 
1,583

 
534

 
(6,798
)
 
775

Property, plant and equipment, net

 

 
782

 
2,513

 

 
3,295

Deferred income taxes

 
18

 
494

 
27

 

 
539

Other assets

 
1,895

 
134

 
399

 
(1,982
)
 
446

Goodwill

 

 
305

 
463

 

 
768

Intangible assets, net

 

 
71

 
103

 

 
174

Total assets
1,888

 
5,545

 
6,046

 
6,575

 
(11,089
)
 
8,965

LIABILITIES AND EQUITY
Current Liabilities
 

 
 

 
 

 
 

 
 

 
 

Short-term borrowings and current installments of long-term debt - third party and affiliates

 
1,625

 
177

 
121

 
(1,782
)
 
141

Trade payables - third party and affiliates

 

 
256

 
543

 
(114
)
 
685

Other liabilities

 
57

 
324

 
493

 
(367
)
 
507

Deferred income taxes

 
16

 
(16
)
 
19

 

 
19

Income taxes payable
(30
)
 
(390
)
 
447

 
20

 
(4
)
 
43

Total current liabilities
(30
)
 
1,308

 
1,188

 
1,196

 
(2,267
)
 
1,395

Noncurrent Liabilities
 
 
 
 
 
 
 
 
 
 
 
Long-term debt

 
2,361

 
820

 
1,636

 
(1,978
)
 
2,839

Deferred income taxes

 

 
36

 
95

 

 
131

Uncertain tax positions
3

 
2

 
28

 
156

 

 
189

Benefit obligations

 

 
1,215

 
139

 

 
1,354

Other liabilities

 
12

 
103

 
1,039

 
(12
)
 
1,142

Total noncurrent liabilities
3

 
2,375

 
2,202

 
3,065

 
(1,990
)
 
5,655

Total Celanese Corporation stockholders’ equity
1,915

 
1,862

 
2,656

 
2,314

 
(6,832
)
 
1,915

Noncontrolling interests

 

 

 

 

 

Total equity
1,915

 
1,862

 
2,656

 
2,314

 
(6,832
)
 
1,915

Total liabilities and equity
1,888

 
5,545

 
6,046

 
6,575

 
(11,089
)
 
8,965



38



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED CONSOLIDATING BALANCE SHEETS
 
As of December 31, 2011
 
Parent
Guarantor
 
Issuer
 
Subsidiary
Guarantors
 
Non-
Guarantors
 
Eliminations
 
Consolidated
 
(In $ millions)
ASSETS
 

 
 

 
 

 
 

 
 

 
 

Current Assets
 

 
 

 
 

 
 

 
 

 
 

Cash and cash equivalents

 

 
133

 
549

 

 
682

Trade receivables - third party and affiliates

 

 
297

 
694

 
(120
)
 
871

Non-trade receivables, net

 
10

 
1,651

 
562

 
(1,988
)
 
235

Inventories, net

 

 
187

 
590

 
(65
)
 
712

Deferred income taxes

 

 
87

 
17

 

 
104

Marketable securities, at fair value

 

 
64

 

 

 
64

Other assets

 
6

 
18

 
45

 
(34
)
 
35

Total current assets

 
16

 
2,437

 
2,457

 
(2,207
)
 
2,703

Investments in affiliates
1,315

 
2,978

 
1,530

 
535

 
(5,534
)
 
824

Property, plant and equipment, net

 

 
735

 
2,534

 

 
3,269

Deferred income taxes

 
17

 
382

 
22

 

 
421

Other assets

 
1,903

 
132

 
296

 
(1,987
)
 
344

Goodwill

 

 
298

 
462

 

 
760

Intangible assets, net

 

 
69

 
128

 

 
197

Total assets
1,315

 
4,914

 
5,583

 
6,434

 
(9,728
)
 
8,518

LIABILITIES AND EQUITY
Current Liabilities
 

 
 

 
 

 
 

 
 

 
 

Short-term borrowings and current installments of long-term debt - third party and affiliates

 
1,492

 
176

 
131

 
(1,655
)
 
144

Trade payables - third party and affiliates

 

 
258

 
535

 
(120
)
 
673

Other liabilities

 
63

 
353

 
506

 
(383
)
 
539

Deferred income taxes

 
16

 
(16
)
 
17

 

 
17

Income taxes payable
(29
)
 
(373
)
 
384

 
35

 
(5
)
 
12

Total current liabilities
(29
)
 
1,198

 
1,155

 
1,224

 
(2,163
)
 
1,385

Noncurrent Liabilities
 
 
 
 
 
 
 
 
 
 
 
Long-term debt

 
2,372

 
834

 
1,650

 
(1,983
)
 
2,873

Deferred income taxes

 

 

 
92

 

 
92

Uncertain tax positions
3

 
16

 
27

 
136

 

 
182

Benefit obligations

 

 
1,346

 
146

 

 
1,492

Other liabilities

 
13

 
99

 
1,055

 
(14
)
 
1,153

Total noncurrent liabilities
3

 
2,401

 
2,306

 
3,079

 
(1,997
)
 
5,792

Total Celanese Corporation stockholders’ equity
1,341

 
1,315

 
2,122

 
2,131

 
(5,568
)
 
1,341

Noncontrolling interests

 

 

 

 

 

Total equity
1,341

 
1,315

 
2,122

 
2,131

 
(5,568
)
 
1,341

Total liabilities and equity
1,315

 
4,914

 
5,583

 
6,434

 
(9,728
)
 
8,518


39



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATING STATEMENTS OF CASH FLOWS
 
Nine Months Ended September 30, 2012
 
Parent
Guarantor
 
Issuer
 
Subsidiary
Guarantors
 
Non-
Guarantors
 
Eliminations
 
Consolidated
 
(In $ millions)
Net cash provided by (used in) operating activities
(28
)
 

 
307

 
382

 

 
661

Investing Activities
 

 
 

 
 

 
 

 
 

 
 

Capital expenditures on property, plant and equipment

 

 
(132
)
 
(138
)
 

 
(270
)
Acquisitions, net of cash acquired

 

 
(23
)
 

 

 
(23
)
Proceeds from sale of businesses and assets, net

 

 
1

 

 

 
1

Deferred proceeds from Kelsterbach plant relocation

 

 

 

 

 

Capital expenditures related to Kelsterbach plant relocation

 

 

 
(43
)
 

 
(43
)
Other, net

 

 
(9
)
 
(53
)
 

 
(62
)
Net cash provided by (used in) investing activities

 

 
(163
)
 
(234
)
 

 
(397
)
Financing Activities
 

 
 

 
 

 
 

 
 

 
 

Short-term borrowings (repayments), net

 

 
2

 
(9
)
 

 
(7
)
Proceeds from long-term debt

 

 

 

 

 

Repayments of long-term debt

 
(11
)
 
(5
)
 
(16
)
 

 
(32
)
Refinancing costs

 

 

 

 

 

Proceeds and repayments from intercompany financing activities

 
11

 
(11
)
 

 

 

Purchases of treasury stock, including related fees
(37
)
 

 

 

 

 
(37
)
Dividends from subsidiary
35

 
35

 

 

 
(70
)
 

Dividends to parent

 
(35
)
 
(35
)
 

 
70

 

Contributions from parent to subsidiary

 

 
(3
)
 
3

 

 

Stock option exercises
58

 

 

 

 

 
58

Series A common stock dividends
(31
)
 

 

 

 

 
(31
)
Preferred stock dividends

 

 

 

 

 

Other, net
29

 

 

 
(1
)
 

 
28

Net cash provided by (used in) financing activities
54

 

 
(52
)
 
(23
)
 

 
(21
)
Exchange rate effects on cash and cash equivalents

 

 

 
3

 

 
3

Net increase (decrease) in cash and cash equivalents
26

 

 
92

 
128

 

 
246

Cash and cash equivalents as of beginning of period

 

 
133

 
549

 

 
682

Cash and cash equivalents as of end of period
26

 

 
225

 
677

 

 
928


40



CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATING STATEMENTS OF CASH FLOWS
 
Nine Months Ended September 30, 2011
 
Parent
Guarantor
 
Issuer
 
Subsidiary
Guarantors
 
Non-
Guarantors
 
Eliminations
 
Consolidated
 
(In $ millions)
Net cash provided by (used in) operating activities
(1
)
 

 
224

 
258

 

 
481

Investing Activities
 

 
 

 
 

 
 

 
 

 
 

Capital expenditures on property, plant and equipment

 

 
(105
)
 
(136
)
 

 
(241
)
Acquisitions, net of cash acquired

 

 
(8
)
 

 

 
(8
)
Proceeds from sale of businesses and assets, net

 

 
1

 
5

 

 
6

Deferred proceeds from Kelsterbach plant relocation

 

 

 
158

 

 
158

Capital expenditures related to Kelsterbach plant relocation

 

 

 
(174
)
 

 
(174
)
Other, net

 

 
(3
)
 
(34
)
 

 
(37
)
Net cash provided by (used in) investing activities

 

 
(115
)
 
(181
)
 

 
(296
)
Financing Activities
 

 
 

 
 

 
 

 
 

 
 

Short-term borrowings (repayments), net

 

 
(9
)
 
(11
)
 

 
(20
)
Proceeds from long-term debt

 
400

 

 
11

 

 
411

Repayments of long-term debt

 
(529
)
 
(2
)
 
(31
)
 

 
(562
)
Refinancing costs

 
(8
)
 

 

 

 
(8
)
Proceeds and repayments from intercompany financing activities

 
137

 
(137
)
 

 

 

Purchases of treasury stock, including related fees
(28
)
 

 

 

 

 
(28
)
Dividends from subsidiary
43

 
143

 

 

 
(186
)
 

Dividends to parent

 
(43
)
 
(43
)
 
(100
)
 
186

 

Contributions from parent to subsidiary

 
(100
)
 
100

 

 

 

Stock option exercises
19

 

 

 

 

 
19

Series A common stock dividends
(25
)
 

 

 

 

 
(25
)
Preferred stock dividends

 

 

 

 

 

Other, net
(8
)
 

 
(3
)
 

 

 
(11
)
Net cash provided by (used in) financing activities
1

 

 
(94
)
 
(131
)
 

 
(224
)
Exchange rate effects on cash and cash equivalents

 

 

 
3

 

 
3

Net increase (decrease) in cash and cash equivalents

 

 
15

 
(51
)
 

 
(36
)
Cash and cash equivalents as of beginning of period

 

 
128

 
612

 

 
740

Cash and cash equivalents as of end of period

 

 
143

 
561

 

 
704




41



22. Subsequent Events
On October 17, 2012, the Company's Board of Directors declared a quarterly cash dividend of $0.075 per share on its Common Stock estimated to be $12 million. The cash dividends are for the period from August 1, 2012 to October 31, 2012 and will be paid on November 8, 2012 to holders of record as of October 29, 2012.

On October 18, 2012, the Company's Board of Directors approved an increase in its share repurchase authorization of the Common Stock to $400 million. As of September 30, 2012 the Company had $136 million remaining under the previous authorization.

42



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The terms the "Company," "we," "our" and "us," refer to Celanese and its subsidiaries on a consolidated basis. The term "Celanese US" refers to the Company’s subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.
The following discussion should be read in conjunction with the Celanese Corporation and Subsidiaries consolidated financial statements as of and for the year ended December 31, 2011, filed on February 10, 2012 with the Securities and Exchange Commission ("SEC") as part of the Company’s Annual Report on Form 10-K (the "2011 Form 10-K") and the unaudited interim consolidated financial statements and notes thereto included elsewhere in this Quarterly Report.
Investors are cautioned that the forward-looking statements contained in this section and other parts of this Quarterly Report involve both risk and uncertainty. Several important factors could cause actual results to differ materially from those anticipated by these statements. Many of these statements are macroeconomic in nature and are, therefore, beyond the control of management. See "Special Note Regarding Forward-Looking Statements" below and at the beginning of our 2011 Form 10-K.
Special Note Regarding Forward-Looking Statements
Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") and other parts of this Quarterly Report contain certain forward-looking statements and information relating to us that are based on the beliefs of our management as well as assumptions made by, and information currently available to, us. You can identify these statements by the fact that they do not relate to matters of a strictly factual or historical nature and generally discuss or relate to forecasts, estimates or other expectations regarding future events. Generally, words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "project," "may," "can," "could," "might," "will" and similar expressions, as they relate to us, are intended to identify forward-looking statements. These statements reflect our current views and beliefs with respect to future events at the time that the statements are made, are not historical facts or guarantees of future performance and are subject to significant risks, uncertainties and other factors that are difficult to predict and many of which are outside of our control. Further, certain forward-looking statements are based upon assumptions as to future events that may not prove to be accurate and, accordingly, should not have undue reliance placed upon them. All forward-looking statements made in this Quarterly Report are made as of the date hereof, and the risk that actual results will differ materially from expectations expressed in this Quarterly Report will increase with the passage of time. We undertake no obligation, and disclaim any duty, to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in our expectations or otherwise.
See Part I - Item 1A. Risk Factors of our 2011 Form 10-K and subsequent periodic filings we make with the SEC for a description of risk factors that could significantly affect our financial results. In addition, the following factors could cause our actual results to differ materially from those results, performance or achievements that may be expressed or implied by such forward-looking statements. These factors include, among other things:
changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate;
the length and depth of product and industry business cycles particularly in the automotive, electrical, textiles, electronics and construction industries;
changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources;
the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases;
the ability to maintain plant utilization rates and to implement planned capacity additions and expansions;
the ability to reduce or maintain at their current levels production costs and improve productivity by implementing technological improvements to existing plants;
increased price competition and the introduction of competing products by other companies;
changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property;

43



costs and potential disruption or interruption of production or operations due to accidents, cyber security incidents, terrorism or political unrest, or other unforeseen events or delays in construction of facilities;
potential liability for remedial actions and increased costs under existing or future environmental regulations, including those relating to climate change;
potential liability resulting from pending or future litigation, or from changes in the laws, regulations or policies of governments or other governmental activities in the countries in which we operate;
changes in currency exchange rates and interest rates;
our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry; and
various other factors, both referenced and not referenced in this Quarterly Report.
Many of these factors are macroeconomic in nature and are, therefore, beyond our control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from those described in this Quarterly Report as anticipated, believed, estimated, expected, intended, planned or projected.
Overview
We are a global technology and specialty materials company. We are one of the world’s largest producers of acetyl products, which are intermediate chemicals, for nearly all major industries, as well as a leading global producer of high performance engineered polymers that are used in a variety of high-value applications. As a recognized innovator in the chemicals industry, we engineer and manufacture a wide variety of products essential to everyday living. Our broad product portfolio serves a diverse set of end-use applications including paints and coatings, textiles, automotive applications, consumer and medical applications, performance industrial applications, filter media, paper and packaging, chemical additives, construction, consumer and industrial adhesives, and food and beverage applications. Our products enjoy leading global positions due to our large global production capacity, operating efficiencies, proprietary production technology and competitive cost structures.
Our large and diverse global customer base primarily consists of major companies in a broad array of industries. We hold geographically balanced global positions and participate in diversified end-use applications. We combine a demonstrated track record of execution, strong performance built on shared principles and objectives, and a clear focus on growth and value creation. Known for operational excellence and execution of our business strategies, we deliver value to customers around the globe with best-in-class technologies.
2012 Highlights:
We announced our new CelFXTM matrix technology for filter media. CelFXTM provides a flexible additive platform for innovation that allows our customers increased filter design flexibility, improved constituent reduction and supports a broad choice for enhancement additives.
We announced plans to construct and operate a methanol production facility at our Clear Lake, Texas acetyl complex which is expected to start up after July 1, 2015. As one of the world's largest producers of acetyl products, this would allow us to utilize our existing infrastructure to capture the opportunities created by abundant and affordable US natural gas supplies.
We announced that the Board of Directors increased our share repurchase authorization to $400 million. As of September 30, 2012, we had $136 million remaining under our previous authorization.
We launched the new SunsationSM platform to help food and beverage manufacturers develop low- and no-calorie products that are better tasting and simplify the formulation process to bring products to market faster.
We entered into an agreement to advance the development of fuel ethanol projects with Pertamina, the state-owned energy company of Indonesia. In line with our long-term strategy to develop new and renewable energy capabilities, Pertamina will collaborate exclusively with us to jointly develop synthetic fuel ethanol projects in the Republic of Indonesia utilizing our proprietary TCX® ethanol process technology.

44



We started up our technology development unit for ethanol production at our facility in Clear Lake, Texas. The unit will support our continuing development of TCX® ethanol process technology for customers in both industrial-grade and fuel ethanol.
We completed the acquisition of certain assets from Ashland Inc., including two product lines, Vinac® and Flexbond®, which will support the strategic growth of our Emulsions business.
We received key government approvals necessary to proceed with previously announced plans to modify and enhance our existing integrated acetyl facility at the Nanjing Chemical Industrial Park in China to produce ethanol for industrial uses. Based upon continued advancements to our TCX® ethanol process technology, we now expect to have approximately 30 to 40 percent additional ethanol production capacity above the originally announced 200,000 tons with no increase in the capital investment for the modification and enhancement. The unit is expected to startup in mid-2013.
Moody's Investors Service and Standard & Poor's Ratings Services both upgraded its outlook for Celanese to "Positive" from "Stable." In raising our outlook, both agencies cited improved operating performance, debt reduction as well as our operational, geographical and product diversity.
We announced that our Board of Directors approved a 25% increase in our quarterly Series A Common Stock cash dividend. The Board of Directors increased the quarterly dividend rate from $0.06 to $0.075 per share of Common Stock on a quarterly basis and $0.24 to $0.30 per share of Common Stock on an annual basis. The new dividend rate became effective in August 2012.

45



Results of Operations

Financial Highlights
 
Three Months Ended
 
 
 
Nine Months Ended
 
 
 
September 30,
 
 
 
September 30,
 
 
 
2012
 
2011
 
Change
 
2012
 
2011
 
Change
 
(unaudited)
 
(In $ millions)
Statement of Operations Data
 

 
 

 
 
 
 

 
 

 
 
Net sales
1,609

 
1,807

 
(198
)
 
4,917

 
5,149

 
(232
)
Gross profit
324

 
401

 
(77
)
 
925

 
1,162

 
(237
)
Selling, general and administrative expenses
(121
)
 
(140
)
 
19

 
(379
)
 
(408
)
 
29

Other (charges) gains, net
2

 
(24
)
 
26

 
(1
)
 
(39
)
 
38

Operating profit (loss)
163

 
196

 
(33
)
 
425

 
593

 
(168
)
Equity in net earnings of affiliates
50

 
57

 
(7
)
 
163

 
146

 
17

Interest expense
(44
)
 
(54
)
 
10

 
(134
)
 
(166
)
 
32

Dividend income - cost investments
1

 
1

 

 
85

 
80

 
5

Earnings (loss) from continuing operations before tax
173

 
201

 
(28
)
 
544

 
661

 
(117
)
Amounts attributable to Celanese Corporation
 

 
 

 


 
 

 
 

 


Earnings (loss) from continuing operations
119

 
167

 
(48
)
 
512

 
510

 
2

Earnings (loss) from discontinued operations
(2
)
 

 
(2
)
 
(2
)
 
2

 
(4
)
Net earnings (loss)
117

 
167

 
(50
)
 
510

 
512

 
(2
)
Other Data
 

 
 

 
 
 
 

 
 

 
 
Depreciation and amortization
78

 
77

 
1

 
227

 
221

 
6

Operating margin(1)
10.1
%
 
10.8
%
 


 
8.6
%
 
11.5
%
 


Other (charges) gains, net
 
 
 
 
 
 
 
 
 
 
 
Employee termination benefits
(1
)
 
(5
)
 
4

 
(2
)
 
(18
)
 
16

Kelsterbach plant relocation
(3
)
 
(14
)
 
11

 
(5
)
 
(43
)
 
38

Plumbing actions
4

 
2

 
2

 
4

 
6

 
(2
)
Commercial disputes
2

 
(7
)
 
9

 
2

 
15

 
(13
)
Other

 

 

 

 
1

 
(1
)
Total other (charges) gains, net
2

 
(24
)
 
26

 
(1
)
 
(39
)
 
38

______________________________
(1) Defined as operating profit (loss) divided by net sales.
 
As of
 
As of
 
September 30,
2012
 
December 31,
2011
 
(unaudited)
 
(In $ millions)
Balance Sheet Data
 

 
 

Cash and cash equivalents
928

 
682

 
 
 
 
Short-term borrowings and current installments of long-term debt - third party and affiliates
141

 
144

Long-term debt
2,839

 
2,873

Total debt
2,980

 
3,017


46



Selected Data by Business Segment
 
Three Months Ended
 
 
 
Nine Months Ended
 
 
 
September 30,
 
 
 
September 30,
 
 
 
2012
 
2011
 
Change
 
2012
 
2011
 
Change
 
(unaudited)
 
(In $ millions, except percentages)
Net Sales
 

 
 

 
 

 
 

 
 
 
 
Advanced Engineered Materials
322

 
332

 
(10
)
 
962

 
1,006

 
(44
)
Consumer Specialties
314

 
298

 
16

 
905

 
855

 
50

Industrial Specialties
297

 
332

 
(35
)
 
933

 
951

 
(18
)
Acetyl Intermediates
785

 
975

 
(190
)
 
2,458

 
2,702

 
(244
)
Other Activities

 

 

 

 
1

 
(1
)
Inter-segment eliminations
(109
)
 
(130
)
 
21

 
(341
)
 
(366
)
 
25

Total
1,609

 
1,807

 
(198
)
 
4,917

 
5,149

 
(232
)
Other (Charges) Gains, Net
 

 
 

 
 

 
 

 
 

 
 

Advanced Engineered Materials
1

 
(13
)
 
14

 
(1
)
 
(42
)
 
41

Consumer Specialties
(1
)
 
2

 
(3
)
 
2

 
(2
)
 
4

Industrial Specialties

 

 

 

 

 

Acetyl Intermediates
1

 
(5
)
 
6

 
2

 
15

 
(13
)
Other Activities
1

 
(8
)
 
9

 
(4
)
 
(10
)
 
6

Total
2

 
(24
)
 
26

 
(1
)
 
(39
)
 
38

Operating Profit (Loss)
 

 
 

 
 

 
 

 
 

 
 

Advanced Engineered Materials
43

 
14

 
29

 
85

 
79

 
6

Consumer Specialties
70

 
66

 
4

 
184

 
168

 
16

Industrial Specialties
23

 
30

 
(7
)
 
76

 
83

 
(7
)
Acetyl Intermediates
62

 
128

 
(66
)
 
199

 
392

 
(193
)
Other Activities
(35
)
 
(42
)
 
7

 
(119
)
 
(129
)
 
10

Total
163

 
196

 
(33
)
 
425

 
593

 
(168
)
Earnings (Loss) From Continuing Operations Before Tax
 

 
 

 
 

 
 

 
 

 
 

Advanced Engineered Materials
88

 
67

 
21

 
228

 
206

 
22

Consumer Specialties
70

 
66

 
4

 
269

 
248

 
21

Industrial Specialties
23

 
31

 
(8
)
 
76

 
84

 
(8
)
Acetyl Intermediates
64

 
131

 
(67
)
 
204

 
399

 
(195
)
Other Activities
(72
)
 
(94
)
 
22

 
(233
)
 
(276
)
 
43

Total
173

 
201

 
(28
)
 
544

 
661

 
(117
)
Depreciation and Amortization
 

 
 

 
 

 
 

 
 

 
 

Advanced Engineered Materials
29

 
27

 
2

 
84

 
68

 
16

Consumer Specialties
13

 
9

 
4

 
33

 
34

 
(1
)
Industrial Specialties
13

 
12

 
1

 
41

 
34

 
7

Acetyl Intermediates
20

 
25

 
(5
)
 
59

 
75

 
(16
)
Other Activities
3

 
4

 
(1
)
 
10

 
10

 

Total
78

 
77

 
1

 
227

 
221

 
6

Operating Margin
 

 
 

 
 

 
 

 
 

 
 

Advanced Engineered Materials
13.4
%
 
4.2
%


 
8.8
%
 
7.9
%



Consumer Specialties
22.3
%
 
22.1
%


 
20.3
%
 
19.6
%



Industrial Specialties
7.7
%
 
9.0
%


 
8.1
%
 
8.7
%



Acetyl Intermediates
7.9
%
 
13.1
%


 
8.1
%
 
14.5
%



Total
10.1
%
 
10.8
%


 
8.6
%
 
11.5
%




47



Factors Affecting Business Segment Net Sales
The percentage increase (decrease) in net sales attributable to each of the factors indicated for each of our business segments is as follows:
Three Months Ended September 30, 2012 Compared to Three Months Ended September 30, 2011
 
Volume
 
Price
 
Currency
 
Other
 
Total
 
(unaudited)
 
(In percentages)
Advanced Engineered Materials
(1
)
 
3

 
(5
)
 
 
(3
)
Consumer Specialties

 
6

 
(1
)
 
 
5

Industrial Specialties
2

 
(8
)
 
(5
)
 
 
(11
)
Acetyl Intermediates
(5
)
 
(11
)
 
(3
)
 
 
(19
)
Total Company
(2
)
 
(6
)
 
(4
)
 
1
 
(11
)
Nine Months Ended September 30, 2012 Compared to Nine Months Ended September 30, 2011
 
Volume
 
Price
 
Currency
 
Other
 
Total
 
(unaudited)
 
(In percentages)
Advanced Engineered Materials
(3
)
 
3

 
(4
)
 
 
(4
)
Consumer Specialties

 
7

 
(1
)
 
 
6

Industrial Specialties
4

 
(2
)
 
(4
)
 
 
(2
)
Acetyl Intermediates
2

 
(8
)
 
(3
)
 
 
(9
)
Total Company
1

 
(3
)
 
(3
)
 
 
(5
)

48



Consolidated Results – Three and Nine Months Ended September 30, 2012 Compared with Three and Nine Months Ended September 30, 2011
Three Months Ended September 30, 2012 Compared with Three Months Ended September 30, 2011
Net sales decreased $198 million during the three months ended September 30, 2012 compared to the same period in 2011 primarily due to lower pricing and volumes in our Acetyl Intermediates segment and unfavorable currency impacts across all our segments due to the stronger dollar against the Euro and the Renminbi. Acetic acid pricing declined significantly compared to 2011 as a result of temporary planned and unplanned production outages across the industry during the three months ended September 30, 2011 which did not occur in 2012. In 2012 softer global demand for acetyl products and derivatives, due to the unfavorable economic conditions in Europe and Asia, and generally lower raw material prices contributed to the decrease in pricing and lower volumes. Consumer Specialties' net sales increased compared to the prior year period, reflecting higher pricing across all regions for Acetate Products due to continued strong demand for Consumer Specialties' value-added applications.
Operating profit decreased $33 million, or 17%, primarily due to lower pricing in our Acetyl Intermediates segment. Lower raw material costs and lower expenses recorded to other (charges) gains, net, in our other segments were not sufficient to offset the decline in operating profit in our Acetyl Intermediates segment. As a percentage of net sales, selling, general and administrative expenses decreased from 7.7% to 7.5% for the three months ended September 30, 2012 as compared to the same period in 2011.
Other (charges) gains, net increased $26 million during the three months ended September 30, 2012 compared to the same period in 2011 primarily due to a reduction of $11 million in costs associated with the relocation of our polyoxymethylene, also commonly known as polyacetal ("POM"), operations in Germany, which are included in our Advanced Engineered Materials segment, as well as a reduction in commercial dispute costs of $9 million. Of the reduction in commercial dispute costs during the three months ended September 30, 2012, $5 million is attributable to our Acetyl Intermediates segment and $4 million to Other Activities.
Our effective income tax rate for the three months ended September 30, 2012 was 31% compared to 17% for the three months ended September 30, 2011 primarily due to changes in uncertain tax positions and increases in losses in jurisdictions not providing tax benefits.
Nine Months Ended September 30, 2012 Compared with Nine Months Ended September 30, 2011
Net sales decreased $232 million during the nine months ended September 30, 2012 compared to the same period in 2011 primarily due to lower pricing in our Acetyl Intermediates segment and unfavorable currency impacts across all our segments. Acetic acid pricing declined significantly during the nine months ended September 30, 2012 compared to the same period in 2011 as a result of temporary planned and unplanned production outages across the industry during the nine months ended September 30, 2011 which did not occur in 2012, as well as unfavorable economic conditions in Europe and Asia. Our Advanced Engineered Materials segment was also impacted by lower demand in Europe and Asia, partially offset by higher demand for automotive applications in North America. Volumes were up for our Acetyl Intermediates and Industrial Specialties segments, but were not sufficient to offset lower pricing and unfavorable currency impacts. Consumer Specialties net sales increased $50 million during the nine months ended September 30, 2012 compared to the same period in 2011, reflecting demand for value-added applications.
Operating profit decreased $168 million or 28% during the nine months ended September 30, 2012 compared to the same period in 2011 primarily due to the lower pricing in our Acetyl Intermediates segment and volatility in ethylene prices, impacting raw material costs. As a percentage of net sales, selling, general and administrative expenses decreased from 7.9% to 7.7% for the nine months ended September 30, 2012 as compared to the same period in 2011 primarily due to a decrease of $15 million in selling, general and administrative expenses in Other Activities.
Other (charges) gains, net increased $38 million for the nine months ended September 30, 2012 as compared to the same period in 2011. During the nine months ended September 30, 2012 and 2011, we recorded $5 million and $43 million, respectively, of expenses related to the relocation of our POM operations in Germany. During the nine months ended September 30, 2012, we recorded no significant employee termination costs as compared to the same period in 2011. See Note 13, Other (Charges) Gains, Net, in the accompanying unaudited interim consolidated financial statements for further information. In 2011, we received consideration of $17 million in connection with the settlement of a claim against a bankrupt supplier. In addition, we recovered an additional $4 million from the settlement of an unrelated commercial dispute, which were both recorded in our Acetyl Intermediates segment. No such settlements occurred in the nine months ended September 30, 2012.

49



Our effective income tax rate for the nine months ended September 30, 2012 was 6% compared to 23% for the nine months ended September 30, 2011. The lower effective tax rate was primarily due to foreign tax credit carryforwards of $142 million recognized during the three months ended March 31, 2012, partially offset by $38 million of deferred tax charges related to changes in our assessment regarding the permanent reinvestment of certain foreign earnings from our Polyplastics Co., Ltd affiliate.
Business Segments – Three and Nine Months Ended September 30, 2012 Compared with Three and Nine Months Ended September 30, 2011
Advanced Engineered Materials
 
Three Months Ended
 
 
 
Nine Months Ended
 
 
 
September 30,
 
 
 
September 30,
 
 
 
2012
 
2011
 
Change
 
2012
 
2011
 
Change
 
(unaudited)
 
(In $ millions, except percentages)
Net sales
322

 
332

 
(10
)
 
962

 
1,006

 
(44
)
Net sales variance
 

 
 

 
 

 
 

 
 

 
 

Volume
(1
)%
 
 

 
 

 
(3
)%
 
 

 
 

Price
3
 %
 
 

 
 

 
3
 %
 
 

 
 

Currency
(5
)%
 
 

 
 

 
(4
)%
 
 

 
 

Other
 %
 
 

 
 

 
 %
 
 

 
 

Other (charges) gains, net
1

 
(13
)
 
14

 
(1
)
 
(42
)
 
41

Operating profit (loss)
43

 
14

 
29

 
85

 
79

 
6

Operating margin
13.4
 %
 
4.2
%
 
 

 
8.8
 %
 
7.9
%
 
 

Equity in net earnings (loss) of affiliates
45

 
52

 
(7
)
 
143

 
125

 
18

Earnings (loss) from continuing operations before tax
88

 
67

 
21

 
228

 
206

 
22

Depreciation and amortization
29

 
27

 
2

 
84

 
68

 
16

Our Advanced Engineered Materials segment develops, produces and supplies a broad portfolio of high performance specialty polymers for application in automotive, medical and electronics products, as well as other consumer and industrial applications. Together with our strategic affiliates, our Advanced Engineered Materials segment is a leading participant in the global specialty polymers industry. Advanced Engineered Materials products are used for a broad range of applications including automotive components, medical devices, electrical and electronics, appliances, battery separators, conveyor belts, filtration equipment, coatings and industrial applications.
Three Months Ended September 30, 2012 Compared with Three Months Ended September 30, 2011
Advanced Engineered Materials’ net sales decreased $10 million for the three months ended September 30, 2012 compared to the same period in 2011 due to lower demand in Europe, partially offset by higher volumes for almost all product lines in North America and Asia. The weak Euro resulted in a significant unfavorable currency impact on net sales, partially offset by higher pricing across almost all product lines.
Operating profit increased $29 million for the three months ended September 30, 2012 compared to the same period in 2011. The change in operating profit was mainly driven by an increase in other (charges) gains, net, as a result of lower costs of $14 million associated with our POM production facility in Frankfurt Hoechst Industrial Park, Germany which began operations during the three months ended September 30, 2011. Higher pricing and lower variable costs as compared to the same period in 2011 contributed an additional $16 million to the increase in operating profit.
Earnings (loss) from continuing operations before tax increased $21 million for the three months ended September 30, 2012 compared to the same period in 2011, reflecting the increase in operating profit, partially offset by the decrease in equity in net earnings of affiliates of $7 million. Net earnings of affiliates decreased primarily due to lower earnings from our Ibn Sina affiliate, driven by lower methyl tertiary-butyl ether ("MTBE") pricing.
Nine Months Ended September 30, 2012 Compared with Nine Months Ended September 30, 2011
Advanced Engineered Materials’ net sales decreased $44 million for the nine months ended September 30, 2012 compared to

50



the same period in 2011 primarily due to lower demand for industrial and consumer goods applications, particularly in Europe and Asia, partially offset by higher volumes related to automotive applications in North America and Asia. The weak Euro had a significant unfavorable currency impact on net sales. Higher pricing across almost all product lines partially offset the lower volumes and unfavorable currency impact.
Operating profit increased $6 million for the nine months ended September 30, 2012 compared to the same period in 2011 as lower relocation expenses more than offset higher operating expenses. Higher depreciation of $16 million, primarily associated with the opening of our POM production facility in Frankfurt Hoechst Industrial Park, Germany during the three months ended September 30, 2011 and higher expenses of $17 million, primarily related to plant maintenance, integrating manufacturing operations from recently acquired product lines and investing in our compounding operations in Asia, were more than offset by a decrease in relocation expenses of $38 million associated with our Frankfurt Hoechst Industrial Park POM operations included in other (charges) gains, net during the nine months ended September 30, 2012 as compared to the prior year period.
Earnings (loss) from continuing operations before tax increased $22 million for the nine months ended September 30, 2012 compared to the same period in 2011 due to an $18 million increase in equity in net earnings of affiliates driven by higher pricing of methanol and MTBE in our Ibn Sina affiliate.
Consumer Specialties
 
Three Months Ended
 
 
 
Nine Months Ended
 
 
 
September 30,
 
 
 
September 30,
 
 
 
2012
 
2011
 
Change
 
2012
 
2011
 
Change
 
(unaudited)
 
(In $ millions, except percentages)
Net sales
314

 
298

 
16

 
905

 
855

 
50

Net sales variance
 

 
 

 
 

 
 

 
 

 
 

Volume
 %
 
 

 
 

 
 %
 
 

 
 

Price
6
 %
 
 

 
 

 
7
 %
 
 

 
 

Currency
(1
)%
 
 

 
 

 
(1
)%
 
 

 
 

Other
 %
 
 

 
 

 
 %
 
 

 
 

Other (charges) gains, net
(1
)
 
2

 
(3
)
 
2

 
(2
)
 
4

Operating profit (loss)
70

 
66

 
4

 
184

 
168

 
16

Operating margin
22.3
 %
 
22.1
%
 
 

 
20.3
 %
 
19.6
%
 
 

Equity in net earnings (loss) of affiliates

 
1

 
(1
)
 
2

 
2

 

Dividend income - cost investments

 

 

 
83

 
78

 
5

Earnings (loss) from continuing operations before tax
70

 
66

 
4

 
269

 
248

 
21

Depreciation and amortization
13

 
9

 
4

 
33

 
34

 
(1
)
Our Consumer Specialties segment consists of our Acetate Products and Nutrinova businesses, which serve consumer-driven applications. Our Acetate Products business is a leading producer and supplier of cellulose acetate flake, film and tow, primarily used in filter products applications. Our Nutrinova business is a leading international supplier of premium quality ingredients for the food, beverage and pharmaceuticals industries.
Three Months Ended September 30, 2012 Compared with Three Months Ended September 30, 2011
Net sales for Consumer Specialties increased $16 million for the three months ended September 30, 2012 as compared to the same period in 2011 primarily due to higher pricing in both the Acetate Products and Nutrinova businesses. Pricing increased across all regions for Acetate Products. Higher volumes in Acetate Products were offset by lower Nutrinova volumes.
Operating profit increased $4 million for the three months ended September 30, 2012, primarily due to the increase in pricing partially offset by a $9 million increase in energy costs, plant maintenance and innovation project costs.
Depreciation and amortization increased $4 million during the three months ended September 30, 2012 as compared to the same period in 2011, primarily due to accelerated depreciation related to additional maintenance-related capital expenditures at our Spondon facility, which will close during the three months ending December 31, 2012.

51



Nine Months Ended September 30, 2012 Compared with Nine Months Ended September 30, 2011
Net sales for Consumer Specialties increased $50 million for the nine months ended September 30, 2012 as compared to the same period in 2011 due to higher pricing in both the Acetate Products and Nutrinova businesses. Pricing increased across all regions for the Acetate Products business. Nutrinova pricing increased primarily due to stronger demand in response to unplanned industry capacity constraints in China. Higher volumes in the Acetate Products business were offset by lower Nutrinova volumes.
Operating profit increased $16 million for the nine months ended September 30, 2012 as compared to the same period in 2011 as higher Acetate Products' pricing more than offset higher raw material and energy costs of $11 million and $11 million, respectively. Plant maintenance costs also increased $22 million as compared to the same period in 2011, including $10 million related to a production outage during the three months ended March 31, 2012.
Earnings (loss) from continuing operations before tax for the nine months ended September 30, 2012 includes an increase of $5 million as compared to the same period in 2011, related to dividends received from our China Acetate ventures. Dividends from the China Acetate ventures are typically received in the second quarter each year.
Industrial Specialties
 
Three Months Ended
 
 
 
Nine Months Ended
 
 
 
September 30,
 
 
 
September 30,
 
 
 
2012
 
2011
 
Change
 
2012
 
2011
 
Change
 
(unaudited)
 
(In $ millions, except percentages)
Net sales
297

 
332

 
(35
)
 
933

 
951

 
(18
)
Net sales variance
 

 
 

 
 

 
 

 
 

 
 

Volume
2
 %
 
 

 
 

 
4
 %
 
 

 
 

Price
(8
)%
 
 

 
 

 
(2
)%
 
 

 
 

Currency
(5
)%
 
 

 
 

 
(4
)%
 
 

 
 

Other
 %
 
 

 
 

 
 %
 
 

 
 

Other (charges) gains, net

 

 

 

 

 

Operating profit (loss)
23

 
30

 
(7
)
 
76

 
83

 
(7
)
Operating margin
7.7
 %
 
9.0
%
 
 

 
8.1
 %
 
8.7
%
 
 

Earnings (loss) from continuing operations before tax
23

 
31

 
(8
)
 
76

 
84

 
(8
)
Depreciation and amortization
13

 
12

 
1

 
41

 
34

 
7

Our Industrial Specialties segment includes our Emulsions and EVA Performance Polymers businesses. Our Emulsions business is a leading global producer of vinyl acetate-based emulsions and develops products and application technologies to improve performance, create value and drive innovation in applications such as paints and coatings, adhesives, construction, glass fiber, textiles and paper. EVA Performance Polymers is a leading North American manufacturer of a full range of low-density polyethylene and specialty EVA resins and compounds. EVA Performance Polymers products are used in many applications, including flexible packaging films, lamination film products, hot melt adhesives, medical products, automotive, carpeting and photovoltaic cells.
Three Months Ended September 30, 2012 Compared with Three Months Ended September 30, 2011
Net sales decreased $35 million for the three months ended September 30, 2012 compared to the same period in 2011. Volumes were up for both Emulsions and EVA Performance Polymers during the three months ended September 30, 2012 compared to the same period in 2011 but were not sufficient to offset lower pricing and unfavorable currency impacts due to the stronger dollar against the Euro and Renminbi. Volumes for Emulsions increased 3% overall, primarily due to strong demand in North America and Asia Pacific, including sales of our recently acquired product lines, Vinac® and Flexbond®, our recent China Emulsions facility expansion and sales of innovative applications, partially offset by lower demand in the European region due to the weak economy. Emulsions product pricing was down in all regions. Lower pricing for EVA Performance Polymers reflects a decline in end-use demand in the North America and Asia.


52



Operating profit decreased $7 million for the three months ended September 30, 2012 compared to the same period in 2011. Slightly higher volumes and lower variable costs of $32 million, of which $22 million related to raw materials, primarily ethylene and vinyl acetate monomer ("VAM"), were not sufficient to offset the lower pricing for EVA Performance Polymers applications.
Nine Months Ended September 30, 2012 Compared with Nine Months Ended September 30, 2011
Net sales decreased $18 million for the nine months ended September 30, 2012 compared to the same period in 2011. Volumes were up for both Emulsions and EVA Performance Polymers during the nine months ended September 30, 2012 compared to the same period in 2011, but were more than offset by lower pricing and unfavorable currency impacts due to the stronger dollar against the Euro and Renminbi. Volumes increased 4% overall for Emulsions primarily due to strong demand in North America and Asia Pacific, including sales of our recently acquired product lines, Vinac® and Flexbond®, our recent China Emulsions facility expansion and sales of innovative applications, partially offset by lower demand in the European region due to a weak economy. Lower pricing for EVA Performance Polymers reflects weaker demand in North America and slower Asia sales.
Operating profit decreased $7 million for the nine months ended September 30, 2012 compared to the same period in 2011 primarily due to lower pricing driven by current economic conditions. Although raw material costs decreased compared to the same period in 2011, lower pricing and higher depreciation and amortization more than offset these savings. Depreciation and amortization increased $7 million due to accelerated depreciation related to efficiency initiatives at our EVA Performance Polymers production facility in Edmonton, Alberta, Canada, as well as increased amortization in Emulsions related to the recent acquisition of finite-lived intangible assets and increased depreciation related to the China capacity expansion.
Acetyl Intermediates
 
Three Months Ended
 
 
 
Nine Months Ended
 
 
 
September 30,
 
 
 
September 30,
 
 
 
2012
 
2011
 
Change
 
2012
 
2011
 
Change
 
(unaudited)
 
(In $ millions, except percentages)
Net sales
785

 
975

 
(190
)
 
2,458

 
2,702

 
(244
)
Net sales variance
 

 
 

 
 

 
 

 
 

 
 

Volume
(5
)%
 
 

 
 

 
2
 %
 
 

 
 

Price
(11
)%
 
 

 
 

 
(8
)%
 
 

 
 

Currency
(3
)%
 
 

 
 

 
(3
)%
 
 

 
 

Other
 %
 
 

 
 

 
 %
 
 

 
 

Other (charges) gains, net
1

 
(5
)
 
6

 
2

 
15

 
(13
)
Operating profit (loss)
62

 
128

 
(66
)
 
199

 
392

 
(193
)
Operating margin
7.9
 %
 
13.1
%
 
 

 
8.1
 %
 
14.5
%
 
 

Equity in net earnings (loss) of affiliates

 
1

 
(1
)
 
3

 
4

 
(1
)
Earnings (loss) from continuing operations before tax
64

 
131

 
(67
)
 
204

 
399

 
(195
)
Depreciation and amortization
20

 
25

 
(5
)
 
59

 
75

 
(16
)
Our Acetyl Intermediates segment produces and supplies acetyl products, including acetic acid, VAM, acetic anhydride and acetate esters. These products are generally used as starting materials for colorants, paints, adhesives, coatings and medicines. This business segment also produces organic solvents and intermediates for pharmaceutical, agricultural and chemical products.
Three Months Ended September 30, 2012 Compared with Three Months Ended September 30, 2011
Acetyl Intermediates’ net sales decreased $190 million during the three months ended September 30, 2012 compared to the same period in 2011 as a result of lower pricing and lower volumes due to weak demand in Europe and Asia as well as unfavorable currency impacts. During the three months ended September 30, 2011, planned and unplanned production outages across the industry resulted in temporarily higher pricing. Similar industry utilization tightness did not occur in the three months ended September 30, 2012.


53



We do not believe current economic conditions are reflective of the value of our acetyl products or those of certain feedstocks. As a result, we took action beginning in the three months ended March 31, 2012 and temporarily idled our 600,000 ton per year Singapore acetic acid plant. Since then, we have periodically resumed operations of this plant and we continue to assess its status based on economic conditions, demand and feedstock costs.
Operating profit decreased $66 million during the three months ended September 30, 2012 compared to the same period in 2011. The decrease in operating profit is primarily due to lower pricing, lower volumes and currency impacts. The negative pricing impact was partially offset by lower raw material costs of $53 million, primarily carbon monoxide, methanol and ethylene, and lower plant maintenance and distribution costs of $13 million.
Other (charges) gains, net increased $6 million for the three months ended September 30, 2012 primarily due to a reduction in commercial dispute costs of $5 million. Depreciation and amortization decreased $5 million due to certain customer-related intangible assets being fully amortized in 2011.
Nine Months Ended September 30, 2012 Compared with Nine Months Ended September 30, 2011
Acetyl Intermediates’ net sales decreased $244 million during the nine months ended September 30, 2012 compared to the same period in 2011 is due to lower pricing and unfavorable currency impacts, partially offset by higher downstream product volumes primarily as a result of higher VAM demand. During the nine months ended September 30, 2011, temporarily elevated industry utilization due to planned and unplanned outages of acetyl producers resulted in higher industry pricing. Acetic acid pricing has declined during the nine months ended September 30, 2012 compared to the same period in 2011 as a result of unfavorable economic conditions in Europe and Asia.
Operating profit decreased $193 million during the nine months ended September 30, 2012 compared to the same period in 2011 primarily due to lower pricing and currency impacts. The decrease in operating profit was somewhat offset by lower raw material costs of $29 million, primarily carbon monoxide and acetone. Energy costs and plant maintenance and distribution costs were also lower by $13 million and $11 million, respectively, during the nine months ended September 30, 2012 compared to the same period in 2011.
Other (charges) gains, net decreased $13 million for the nine months ended September 30, 2012 compared to the same period in 2011. During the nine months ended September 30, 2011, we received consideration of $17 million in connection with the settlement of a claim against a bankrupt supplier and $4 million for the resolution of a commercial dispute, offset by employee termination benefits of $4 million relating to the closure of our Pardies facility. Depreciation and amortization decreased $16 million mainly due to certain customer-related intangibles being fully amortized in 2011.
Other Activities
Other Activities primarily consists of corporate center costs, including financing and administrative activities such as legal, accounting and treasury functions, interest income and expense associated with our financing and our captive insurance companies.
Three Months Ended September 30, 2012 Compared with Three Months Ended September 30, 2011
Operating loss of $35 million for Other Activities decreased $7 million for the three months ended September 30, 2012 compared to the same period in 2011, primarily due to a decrease in costs associated with business optimization initiatives, executive compensation and other productivity restructuring expenses, with other (charges) gains, net increasing by $9 million, partially offset by unfavorable currency fluctuations. The increase of $9 million in other (charges) gains, net during the three months ended September 30, 2012 is due to the absence of $4 million in commercial dispute costs and a decrease in termination benefit costs of $6 million, related to one of our business optimization initiatives.
Nine Months Ended September 30, 2012 Compared with Nine Months Ended September 30, 2011
Operating loss of $119 million for Other Activities decreased $10 million for the nine months ended September 30, 2012 compared to the same period in 2011. Selling, general and administrative expenses were lower by $15 million and other (charges) gains, net were higher by $6 million. Selling, general and administrative expenses were lower primarily due to a decrease in costs associated with business optimization initiatives, executive compensation and other productivity restructuring related expenses. Other (charges) gains, net were higher for the nine months ended September 30, 2012 primarily due to the absence of $4 million in commercial dispute costs as compared to the same period in 2011. Offsetting these lower costs were captive insurance reserve adjustments of $7 million.

54



Liquidity and Capital Resources
Our primary source of liquidity is cash generated from operations, available cash and cash equivalents and dividends from our portfolio of strategic investments. In addition, as of September 30, 2012 we have $158 million available for borrowing under our credit-linked revolving facility and $600 million available under our revolving credit facility to assist, if required, in meeting our working capital needs and other contractual obligations.
While our contractual obligations, commitments and debt service requirements over the next several years are significant, we continue to believe we will have available resources to meet our liquidity requirements, including debt service, for the next twelve months. If our cash flow from operations is insufficient to fund our debt service and other obligations, we may be required to use other means available to us such as increasing our borrowings, reducing or delaying capital expenditures, seeking additional capital or seeking to restructure or refinance our indebtedness. There can be no assurance, however, that we will continue to generate cash flows at or above current levels.
In July 2012, we completed construction of a technology development unit for ethanol production at our facility in Clear Lake, Texas. We also completed construction of a new research and development facility at our Clear Lake site to continue the advancement of our acetyl and TCX® technologies.
In June 2012, we announced our intent to build a new 1.3 million ton per year methanol plant in Clear Lake, Texas. The unit is expected to start up in July 2015. We are currently evaluating various strategic alternatives that would allow us to share the off-take and minimize the capital expenditures of this planned facility.
In January 2011, we signed letters of intent to construct and operate one, and possibly two, industrial ethanol production facilities in China. The potential sites were Nanjing, China at the Nanjing Chemical Industrial Park, and Zhuhai, China at the Gaolan Port Economic Zone. We expect to begin industrial ethanol production within 30 months following project approvals with anticipated initial nameplate capacity of 400,000 tons per year per unit and an initial investment of approximately $300 million per unit. 
In June 2011, we announced our plans to modify and enhance our existing integrated acetyl facility at the Nanjing Chemical Industrial Park with our TCX® advanced technology. In March 2012, we received key government approvals necessary to proceed with our plans to modify and enhance our Nanjing facility. The unit is expected to startup in mid-2013 with a capacity of approximately 275,000 tons per year.
In April 2010, we announced that, through our strategic affiliate Ibn Sina, we will construct a 50,000 ton POM production facility in Saudi Arabia. Our pro rata share of invested capital in the POM expansion is expected to total approximately $165 million over a five year period which began in late 2010.
As a result of the National Emission Standard for Hazardous Air Pollutants for Industrial, Commercial, and Institutional Boilers and Process Heaters ("Boiler MACT") regulations discussed in Item 1A. Risk Factors in our 2011 Form 10-K, we preliminarily estimate our costs in the US to approximate $150 million in total over the next four years, depending on the timing and requirements of the final rule.
In addition to exit-related costs associated with the closure of the Spondon, Derby, United Kingdom acetate flake and tow manufacturing operations, we expect to incur capital expenditures in certain capacity and efficiency improvements, principally at our Lanaken, Belgium facility, to optimize our global production network.
Total cash outflows for capital expenditures, including the specific projects above, are expected to be in the range of $325 million to $350 million in 2012, excluding approximately €43 million related to the relocation of our POM plant in Kelsterbach and capacity expansion in Europe. Per the terms of our agreement with the Frankfurt, Germany Airport, we ceased POM operations at our Kelsterbach, Germany facility prior to July 31, 2011 and in September 2011 announced the opening of our new POM production facility in Frankfurt Hoechst Industrial Park, Germany.
In December 2009, we announced plans with China National Tobacco Corporation to expand the acetate flake and tow capacity at the venture’s Nantong facility and in 2010 we received formal approval to expand flake and tow capacities, each by 30,000 tons. Our Chinese Acetate ventures fund their operations using operating cash flow. During 2011 and 2010, we made contributions related to the capacity expansion in Nantong of $8 million and $12 million, respectively. We contributed an additional $9 million to the Nantong expansion during the nine months ended September 30, 2012.

55



On a stand-alone basis, Celanese has no material assets other than the stock of its subsidiaries and no independent external operations of its own. As such, Celanese generally will depend on the cash flow of its subsidiaries and their abilities to pay dividends and make other distributions to Celanese in order for Celanese to meet its obligations, including its obligations under its senior credit facilities and its senior notes and to pay dividends on its Series A common stock.
Cash Flows
Cash and cash equivalents increased $246 million to $928 million as of September 30, 2012 as compared to December 31, 2011. As of September 30, 2012, $677 million of the $928 million of cash and cash equivalents was held by our foreign subsidiaries. If these funds are needed for our operations in the US, we may be required to accrue and pay US taxes to repatriate these funds. Our intent is to permanently reinvest these funds outside of the US, with the possible exception of funds that have been previously subject to US federal and state taxation. Our current plans do not demonstrate a need to repatriate cash held by our foreign subsidiaries in a taxable transaction to fund our US operations.
Net Cash Provided by Operating Activities
Cash flow provided by operations increased $180 million for the nine months ended September 30, 2012 as compared to the same period in 2011, with cash inflows increasing from $481 million to $661 million. Cash flow provided by operations was negatively impacted by the decrease in earnings from continuing operations, but positively impacted by an increase in dividends received from investments in affiliates and the change in trade working capital. Trade working capital was primarily impacted by a lower increase in trade receivables, a decrease in inventory, partially offset by an increase in trade payables. Trade receivables increased primarily due to the timing of payments at September 30, 2012. Inventories decreased primarily due to higher inventory turnover and lower production in Asia compared to the prior year. Trade payables increased primarily due to increases in purchases of raw materials and expenditures on capital projects. The increase in cash provided by operations was also positively impacted by lower benefit plan contributions made during the nine months ended September 30, 2012 as compared to the same period in 2011. Employer pension and other postretirement benefit contributions were $154 million during the nine months ended September 30, 2012 compared to $166 million for the same period in 2011.
Trade working capital is calculated as follows:
 
As of
 
As of
 
As of
 
As of
 
September 30,
2012
 
December 31,
2011
 
September 30,
2011
 
December 31,
2010
 
(unaudited)
 
(In $ millions)
Trade receivables, net
932

 
871

 
978

 
827

Inventories
711

 
712

 
777

 
610

Trade payables - third party and affiliates
(685
)
 
(673
)
 
(713
)
 
(673
)
Trade working capital
958

 
910

 
1,042

 
764

Net Cash Used in Investing Activities
Net cash used in investing activities increased $101 million for the nine months ended September 30, 2012 as compared to the same period in 2011, with cash outflows increasing from $296 million to $397 million. During the nine months ended September 30, 2011, we received $158 million from the Frankfurt, Germany Airport related to the relocation of our Kelsterbach, Germany POM operations. No such proceeds were received in 2012. In addition, capital expenditures during the nine months ended September 30, 2012 related to the relocation and expansion of our Kelsterbach POM operations were $131 million lower than in the same period in 2011, offset by an increase in capital expenditures unrelated to the relocation and expansion of our Kelsterbach POM operations of $29 million.
Net Cash Provided by (Used in) Financing Activities
Net cash used in financing activities decreased $203 million for the nine months ended September 30, 2012. The change in cash used in financing activities is primarily related to $132 million of lower net repayments of short-term borrowings and long-term debt and $39 million of higher proceeds from stock option exercises when compared to the same period in 2011.

56



Debt and Other Obligations
Senior Notes
In September 2010, Celanese US completed the private placement of 600 million in aggregate principal amount of 6.625% senior unsecured notes due 2018 (the "6.625% Notes") under an indenture dated September 24, 2010 (the "Indenture") among Celanese US, Celanese, the Subsidiary Guarantors and Wells Fargo Bank, National Association, as trustee. In April 2011, Celanese US registered the 6.625% Notes under the Securities Act of 1933, as amended (the "Securities Act"). Celanese US pays interest on the 6.625% Notes on April 15 and October 15 of each year which commenced on April 15, 2011. The 6.625% Notes are redeemable, in whole or in part, at any time on or after October 15, 2014 at the redemption prices specified in the Indenture. Prior to October 15, 2014, Celanese US may redeem some or all of the 6.625% Notes at a redemption price of 100% of the principal amount, plus accrued and unpaid interest, if any, to the redemption date, plus a "make-whole" premium as specified in the Indenture. The 6.625% Notes are senior unsecured obligations of Celanese US and rank equally in right of payment with all other unsubordinated indebtedness of Celanese US. The 6.625% Notes are guaranteed on a senior unsecured basis by Celanese and each of the domestic subsidiaries of Celanese US that guarantee its obligations under its senior secured credit facilities (the "Subsidiary Guarantors").
The Indenture contains covenants, including, but not limited to, restrictions on our ability to incur indebtedness; grant liens on assets; merge, consolidate, or sell assets; pay dividends or make other restricted payments; engage in transactions with affiliates; or engage in other businesses.
Additionally, in May 2011, Celanese US completed an offering of $400 million in aggregate principal amount of 5.875% senior unsecured notes due 2021 (the "5.875% Notes") in a public offering registered under the Securities Act. The 5.875% Notes are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors.
The 5.875% Notes were issued under an indenture and a first supplemental indenture, each dated May 6, 2011 (the "First Supplemental Indenture") among Celanese US, Celanese, the Subsidiary Guarantors and Wells Fargo Bank, National Association, as trustee. Celanese US pays interest on the 5.875% Notes on June 15 and December 15 of each year which commenced on December 15, 2011. Prior to June 15, 2021, Celanese US may redeem some or all of the 5.875% Notes at a redemption price of 100% of the principal amount, plus accrued and unpaid interest, if any, to the redemption date, plus a "make-whole" premium as specified in the First Supplemental Indenture. The 5.875% Notes are senior unsecured obligations of Celanese US and rank equally in right of payment with all other unsubordinated indebtedness of Celanese US.
The First Supplemental Indenture contains covenants, including, but not limited to, restrictions on our ability to incur indebtedness; grant liens on assets; merge, consolidate, or sell assets; pay dividends or make other restricted payments; engage in transactions with affiliates; or engage in other businesses.
Senior Credit Facilities
In September 2010, we entered into an amendment agreement with the lenders under our existing senior secured credit facilities in order to amend and restate the corresponding credit agreement, dated as of April 2, 2007 (as previously amended, the "Existing Credit Agreement", and as amended and restated by the amendment agreement, the "Amended Credit Agreement"). Our Amended Credit Agreement consists of the Term C loan facility due 2016, the Term B loan facility due 2014, a $600 million revolving credit facility terminating in 2015 and a $228 million credit-linked revolving facility terminating in 2014.
In May 2011, Celanese US, through its subsidiaries, prepaid the outstanding Term B loan facility under the Amended Credit Agreement set to mature in 2014 in an aggregate principal amount of $516 million using proceeds from the 5.875% Notes and cash on hand. The prepaid principal amount was comprised of $414 million of US dollar-denominated Term B loan facility and €69 million of Euro-denominated Term B loan facility.

57



The balances available for borrowing under the revolving credit facility and the credit-linked revolving facility are as follows:
 
As of
 
September 30,
2012
 
(unaudited)
 
(In $ millions)
Revolving Credit Facility
 

Borrowings outstanding

Letters of credit issued

Available for borrowing
600

Credit-Linked Revolving Facility
 

Letters of credit issued
70

Available for borrowing
158

As a condition to borrowing funds or requesting that letters of credit be issued under the revolving credit facility, our first lien senior secured leverage ratio (as calculated as of the last day of the most recent fiscal quarter for which financial statements have been delivered under the revolving facility) cannot exceed the threshold as specified below. Further, our first lien senior secured leverage ratio must be maintained at or below that threshold while any amounts are outstanding under the revolving credit facility.
Our amended first lien senior secured leverage ratios and the borrowing capacity under the revolving credit facility are as follows:
 
As of September 30, 2012
 
First Lien Senior Secured Leverage Ratio
 
 
 
Maximum
 
Estimate
 
Estimate, If Fully Drawn
 
 Borrowing Capacity
 
(unaudited)
 
 
 
 
 
 
 
(In $ millions)
Revolving credit facility
3.90
 
1.15
 
1.63
 
600

The Amended Credit Agreement contains covenants including, but not limited to, restrictions on our ability to incur indebtedness; grant liens on assets; merge, consolidate, or sell assets; pay dividends or make other restricted payments; make investments; prepay or modify certain indebtedness; engage in transactions with affiliates; enter into sale-leaseback transactions or hedge transactions; or engage in other businesses.
We are in compliance with all of the covenants related to our debt agreements as of September 30, 2012.
Share Capital
Our Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of our Series A Common Stock, par value $0.0001 per share ("Common Stock") unless the Board of Directors, in its sole discretion, determines otherwise. The amount available to pay cash dividends is restricted by our Amended Credit Agreement, the 6.625% Notes and the 5.875% Notes.
On April 23, 2012, we announced that our Board of Directors approved a 25% increase in our quarterly Common Stock cash dividend. The Board of Directors increased the quarterly dividend rate from $0.06 to $0.075 per share of Common Stock on a quarterly basis and $0.24 to $0.30 per share of Common Stock on an annual basis. The new dividend rate became effective in August 2012.

58



Our Board of Directors authorized the repurchase of our Common Stock as follows:
 
 
Authorized Amount
 
 
(unaudited)
 
 
(In $ millions)
February 2008
 
400

October 2008
 
100

April 2011
 
129

As of September 30, 2012
 
629

These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program does not have an expiration date.
The share repurchase activity pursuant to this authorization is as follows:
 
Nine Months Ended
 
Total From
February 2008 Through
 
September 30,
 
 
2012
 
2011
 
September 30, 2012
 
(unaudited)
Shares repurchased
853,388

 
591,356

 
12,936,196

Average purchase price per share
$
43.19

 
$
47.37

 
$
38.12

Amount spent on repurchased shares (in millions)
$
37

 
$
28

 
$
493


On October 18, 2012, our Board of Directors approved an increase in our share repurchase authorization of our Common Stock to $400 million. As of September 30, 2012, we had $136 million remaining under the previous authorization.
The purchase of treasury stock reduces the number of shares outstanding and the repurchased shares may be used by us for compensation programs utilizing our stock and other corporate purposes. We account for treasury stock using the cost method and include treasury stock as a component of stockholders’ equity.
Contractual Obligations
Except as otherwise described in this report, there have been no material revisions outside the ordinary course of business to our contractual obligations as described in our 2011 Form 10-K.
Off-Balance Sheet Arrangements
We have not entered into any material off-balance sheet arrangements.
Critical Accounting Policies and Estimates
Our unaudited interim consolidated financial statements are based on the selection and application of significant accounting policies. The preparation of unaudited interim consolidated financial statements in conformity with US Generally Accepted Accounting Principles ("US GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of revenues, expenses and allocated charges during the reporting period. Actual results could differ from those estimates. However, we are not currently aware of any reasonably likely events or circumstances that would result in materially different results.
We describe our significant accounting policies in Note 2, Summary of Accounting Policies, of the Notes to Consolidated Financial Statements included in our 2011 Form 10-K. We discuss our critical accounting policies and estimates in MD&A in our 2011 Form 10-K.
There have been no material revisions to the critical accounting policies as filed in our 2011 Form 10-K.

59



Recent Accounting Pronouncements
See Note 2, Recent Accounting Pronouncements, in the accompanying unaudited interim consolidated financial statements included in this Quarterly Report on Form 10-Q for a discussion of recent accounting pronouncements.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Market risk for our Company has not changed materially from the foreign exchange, interest rate and commodity risks disclosed in Item 7A. Quantitative and Qualitative Disclosures about Market Risk in our 2011 Form 10-K. See also Note 15, Derivative Financial Instruments, in the accompanying unaudited interim consolidated financial statements for further discussion of our market risk management and the related impact on our financial position and results of operations.
Item 4. Controls and Procedures
Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based on that evaluation, as of September 30, 2012, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective.
Changes in Internal Control Over Financial Reporting
During the period covered by this report, there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

60



PART II — OTHER INFORMATION
Item 1. Legal Proceedings
We are involved in a number of legal and regulatory proceedings, lawsuits and claims incidental to the normal conduct of our business, relating to such matters as product liability, land disputes, contracts, antitrust, intellectual property, workers' compensation, chemical exposure, asbestos exposure, prior acquisitions and divestitures, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where it is named as a defendant. Due to the inherent subjectivity of assessments and unpredictability of outcomes of legal proceedings, the Company's litigation accruals and estimates of possible loss or range of possible loss may not represent the ultimate loss to the Company from legal proceedings. See Note 11, Environmental, and Note 17, Commitments and Contingencies, in the accompanying unaudited interim consolidated financial statements for a discussion of material environmental matters and commitments and contingencies related to legal and regulatory proceedings. There have been no significant developments in the "Legal Proceedings" described in our 2011 Form 10-K other than those disclosed in Note 11, Environmental, and Note 17, Commitments and Contingencies, in the accompanying unaudited interim consolidated financial statements.
Item 1A. Risk Factors
There have been no material changes to the risk factors under Part I, Item 1A of our 2011 Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The table below sets forth information regarding repurchases of our Common Stock during the three months ended September 30, 2012:
Period
 
Total Number
of Shares Purchased
 
Average
Price Paid per Share
 
Total Number of
Shares Purchased as
Part of Publicly Announced Program
 
Approximate Dollar
Value of Shares
Remaining that may be
Purchased Under the Program
(2)
(unaudited)
July 1-31, 2012
 
90,873

(1) 
$
34.76

 
90,480

 
$
141,000,000

August 1-31, 2012
 
62,742

 
$
39.82

 
62,742

 
$
139,000,000

September 1-30, 2012
 
63,456

 
$
39.45

 
63,456

 
$
136,000,000

Total
 
217,071

 
 
 
216,678

 
 
______________________________
(1) 
Includes 393 shares withheld from employees to cover their statutory minimum withholding requirements for personal income taxes related to the vesting of restricted stock units.
(2) 
Our Board of Directors authorized the repurchase of our Common Stock as follows:
 
Authorized Amount
 
(In $ millions)
February 2008
400

October 2008
100

April 2011
129

As of September 30, 2012
629

Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
None.

61



Item 6. Exhibits
Exhibit Number                    Description
3.1
Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Annual Report on Form 10-K filed with the SEC on February 11, 2011).
3.2
Third Amended and Restated By-laws, effective as of October 23, 2008 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on October 29, 2008).
10.1*‡
Letter Agreement, dated September 8, 2012, between Celanese Corporation and Lori A. Johnston.
12.1*
Statement of Computation of Ratio of Earnings to Fixed Charges.
31.1*
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*
XBRL Instance Document.
101.SCH*
XBRL Taxonomy Extension Schema Document.
101.CAL*
XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*
XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*
XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*
XBRL Taxonomy Extension Presentation Linkbase Document.
*     Filed herewith
‡ Indicates a management contract or compensatory plan or arrangement


62



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CELANESE CORPORATION
 
By: 
 /s/ MARK C. ROHR
Mark C. Rohr
Chairman of the Board of Directors and
Chief Executive Officer
Date: October 23, 2012

 
By: 
 /s/ STEVEN M. STERIN
Steven M. Sterin
Senior Vice President and
Chief Financial Officer
Date: October 23, 2012

63